| 1 |
Zhao G, Xiang G, Hu X, Qiao Y, Ma S, Tian Y, Gao X, Liu F, Li X, Shi G. Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China. Eur J Cancer Prev 2023. [PMID: 36942852 DOI: 10.1097/CEJ.0000000000000775] [Reference Citation Analysis]
|
| 2 |
Momeni-Boroujeni A, Vanderbilt C, Yousefi E, Abu-Rustum NR, Aghajanian C, Soslow RA, Ellenson LH, Weigelt B, Murali R. Landscape of chromatin remodeling gene alterations in endometrial carcinoma. Gynecol Oncol 2023;172:54-64. [PMID: 36958196 DOI: 10.1016/j.ygyno.2023.03.010] [Reference Citation Analysis]
|
| 3 |
Li M, Zhu C, Xue Y, Miao C, He R, Li W, Zhang B, Yu W, Huang X, Lv M, Xu Y, Huang Q. A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer. Br J Cancer 2023. [PMID: 36828869 DOI: 10.1038/s41416-023-02155-8] [Reference Citation Analysis]
|
| 4 |
Islam MA, Hossen MB, Horaira MA, Hossen MA, Kibria MK, Reza MS, Tuly KF, Faruqe MO, Kabir F, Mahumud RA, Mollah MNH. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer. Cancers (Basel) 2023;15. [PMID: 36900162 DOI: 10.3390/cancers15051369] [Reference Citation Analysis]
|
| 5 |
Abdullah M, Meilany S, Trimarsanto H, Malik SG, Sukartini N, Idrus F, Nursyirwan SA, Muzellina VN, Pribadi RR, Utari AP, Maulahela H, Syam AF. Genomic profiles of Indonesian colorectal cancer patients. F1000Res 2023;11:443. [DOI: 10.12688/f1000research.109136.2] [Reference Citation Analysis]
|
| 6 |
Olguin JE, Mendoza-Rodriguez MG, Sanchez-Barrera CA, Terrazas LI. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment? World J Gastrointest Oncol 2023; 15(2): 251-267 [DOI: 10.4251/wjgo.v15.i2.251] [Reference Citation Analysis]
|
| 7 |
Kunt N, Araz M, Yildirim MS, Findik S, Kocak MZ, Eryilmaz MK, Artac M. The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers.. [DOI: 10.21203/rs.3.rs-2553560/v1] [Reference Citation Analysis]
|
| 8 |
Gaab ME, Lozano PO, Ibañez D, Manese KD, Riego FM, Tiongco RE, Albano PM. A Meta-Analysis on the Association of Colibactin-Producing pks+ Escherichia coli with the Development of Colorectal Cancer. Lab Med 2023;54:75-82. [PMID: 35960765 DOI: 10.1093/labmed/lmac072] [Reference Citation Analysis]
|
| 9 |
Qiu YY, Zeng YX, Cheng Y. Are High Levels of Microsatellite Instability and Microsatellite Stability Identical in DNA Mismatch Repair-Deficient Colorectal Cancer Patients? Can J Gastroenterol Hepatol 2023;2023:8370262. [PMID: 36937571 DOI: 10.1155/2023/8370262] [Reference Citation Analysis]
|
| 10 |
Zheng M, Wang W, Bu Y, Liu J, Ma J, Wang R, Ren X, Lu Z, Li J, Cai J. Pan-Cancer Analysis of the Roles and Driving Forces of RAB42. Biomolecules 2022;13. [PMID: 36671428 DOI: 10.3390/biom13010043] [Reference Citation Analysis]
|
| 11 |
Hryhorowicz S, Kaczmarek-Ryś M, Lis-Tanaś E, Porowski J, Szuman M, Grot N, Kryszczyńska A, Paszkowski J, Banasiewicz T, Pławski A. Strong Hereditary Predispositions to Colorectal Cancer. Genes (Basel) 2022;13. [PMID: 36553592 DOI: 10.3390/genes13122326] [Reference Citation Analysis]
|
| 12 |
Ou S, Xu Y, Liu Q, Yang T, Chen W, Yuan X, Zuo X, Yao J, Shi P. Big data mining to screen hub molecular targets related to metabolic abnormalities, intestinal polyps and colorectal cancer.. [DOI: 10.21203/rs.3.rs-2336031/v1] [Reference Citation Analysis]
|
| 13 |
Jothimani G, Ganesan H, Pathak S, Banerjee A. Molecular Characterization of Primary and Metastatic Colon Cancer Cells to Identify Therapeutic Targets with Natural Compounds. Curr Top Med Chem 2022;22:2598-615. [PMID: 35366775 DOI: 10.2174/1568026622666220401161511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Zhang Y, Han L, Zhang Q, Liu Z, Niu H, Li L, Hu J, Shi X, Ding Z, Qian X. Exploring the expression and the prognosis of mismatch repair protein and PD-L1 in colorectal cancer.. [DOI: 10.21203/rs.3.rs-2287083/v1] [Reference Citation Analysis]
|
| 15 |
Huang K, Lin B, Liu J, Liu Y, Li J, Tian G, Yang J. Predicting colorectal cancer tumor mutational burden from histopathological images and clinical information using multi-modal deep learning. Bioinformatics 2022;38:5108-15. [PMID: 36130268 DOI: 10.1093/bioinformatics/btac641] [Reference Citation Analysis]
|
| 16 |
Niu Y, Yang W, Qian H, Sun Y. Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated. Cancer Cell Int 2022;22:341. [DOI: 10.1186/s12935-022-02766-w] [Reference Citation Analysis]
|
| 17 |
Lulli M, Napoli C, Landini I, Mini E, Lapucci A. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. IJMS 2022;23:13431. [DOI: 10.3390/ijms232113431] [Reference Citation Analysis]
|
| 18 |
Ramos Zapatero M, Tong A, Sufi J, Vlckova P, Cardoso Rodriguez F, Nattress C, Qin X, Hochhauser D, Krishnaswamy S, Tape CJ. Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug Responses.. [DOI: 10.1101/2022.10.19.512668] [Reference Citation Analysis]
|
| 19 |
Brawley OW. Disparities in Cancer Care. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm075.pub2] [Reference Citation Analysis]
|
| 20 |
Maag N, Arndt A, Steinestel K. Lasermikrodissektion zur Analyse molekularer Heterogenität im kolorektalen Karzinom. Pathologie 2022. [DOI: 10.1007/s00292-022-01131-y] [Reference Citation Analysis]
|
| 21 |
Akbulut S, Küçükakçali Z, Çolak C. XGBoost modeli ile gen dizileme verilerine dayalı kolorektal kanserin sınıflandırılması: Bir halk sağlığı bilişimi uygulaması. Cukurova Med J 2022;47:1179-1186. [DOI: 10.17826/cumj.1128653] [Reference Citation Analysis]
|
| 22 |
Ballester V, Cruz-Correa M. Approach to Familial Predisposition to Colorectal Cancer. Gastroenterol Clin North Am 2022;51:593-607. [PMID: 36153112 DOI: 10.1016/j.gtc.2022.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Devall MA, Eaton S, Ali MW, Powell SM, Li L, Casey G. Insights into Early Onset Colorectal Cancer through Analysis of Normal Colon Organoids of Familial Adenomatous Polyposis Patients. Cancers (Basel) 2022;14. [PMID: 36077675 DOI: 10.3390/cancers14174138] [Reference Citation Analysis]
|
| 24 |
Jin C, Zhao JS, Huang XQ, Yang XZ, Niu FY, Lin JR, Ma L, Shi YX, Li XS, Jiang P, Gao S, Li F, Song Y. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35947245 DOI: 10.1007/s12072-022-10375-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Zhang T, Yu H, Dai X, Zhang X. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment. Front Immunol 2022;13:971428. [DOI: 10.3389/fimmu.2022.971428] [Reference Citation Analysis]
|
| 26 |
Rao CV, Xu C, Zhang Y, Asch AS, Yamada HY. Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations. Sci Rep 2022;12:11739. [PMID: 35817785 DOI: 10.1038/s41598-022-15692-8] [Reference Citation Analysis]
|
| 27 |
Wei L, Duan L, Zhao H, Tai J. Role of a mixed probiotic product, VSL#3, in the prevention and treatment of colorectal cancer. Eur J Pharmacol 2022;:175152. [PMID: 35835181 DOI: 10.1016/j.ejphar.2022.175152] [Reference Citation Analysis]
|
| 28 |
Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, Sharma A, Maacha S, Karedath T, Hashem S, Yasin SB, Bagga P, Reddy R, Frennaux MP, Uddin S, Dhawan P, Haris M, Macha MA. Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. Cancer Communications. [DOI: 10.1002/cac2.12295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Natalia Krasteva, Milena Georgieva. Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials. Pharmaceutics 2022;14:1213. [PMID: 35745786 DOI: 10.3390/pharmaceutics14061213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 30 |
Al-jussani GN, Alsughayer A, Yousuf MS, Mullahuwash Y, Dabbagh T, Sughayer MA. The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma. Int J Biol Markers. [DOI: 10.1177/03936155221104122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 31 |
Wong GYM, Diakos C, Hugh TJ, Molloy MP. Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases. IJMS 2022;23:6091. [DOI: 10.3390/ijms23116091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Kamel F, Schneider N, Nisar P, Soloviev M. Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer. Cancers 2022;14:2654. [DOI: 10.3390/cancers14112654] [Reference Citation Analysis]
|
| 33 |
Abdullah M, Meilany S, Trimarsanto H, Malik SG, Sukartini N, Idrus F, Nursyirwan SA, Muzellina VN, Pribadi RR, Utari AP, Maulahela H, Syam AF. Genomic profiles of Indonesian colorectal cancer patients. F1000Res 2022;11:443. [DOI: 10.12688/f1000research.109136.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Symonds L, Yu M, Zhang Y, Ou FS, Zemla TJ, Carter K, Bertagnolli M, Innocenti F, Bosch LJ, Meijer GA, Carvalho B, Grady WM, Cohen SA. Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance). Epigenetics 2022;:1-11. [PMID: 35412430 DOI: 10.1080/15592294.2022.2058225] [Reference Citation Analysis]
|
| 35 |
Kamel F, Eltarhoni K, Nisar P, Soloviev M. Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers 2022;14:1889. [DOI: 10.3390/cancers14081889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Chen X, Hu M, Chen Y, Li A, Hua Y, Jiang H, Li H, Lin M. Targeted deep sequencing reveals APC mutations as predictors of overall survival in Chinese colorectal patients receiving adjuvant chemotherapy. Scand J Gastroenterol 2022;57:465-72. [PMID: 34978498 DOI: 10.1080/00365521.2021.2022189] [Reference Citation Analysis]
|
| 37 |
Li C, Song J, Guo Z, Gong Y, Zhang T, Huang J, Cheng R, Yu X, Li Y, Chen L, Ma X, Sun Y, Wang Y, Xue L. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment. Front Immunol 2022;13:857808. [DOI: 10.3389/fimmu.2022.857808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Shut SA, Platoshkin VE, Platoshkina TV, Nikulina NA, Nikolaeva NV. Innovative approaches to colorectal cancer prevention. jour 2022;19:13-20. [DOI: 10.51523/2708-6011.2022-19-1-02] [Reference Citation Analysis]
|
| 39 |
Guo S, Li T, Xu D, Xu J, Wang H, Li J, Bi X, Cao M, Xu Z, Xia Q, Cui Y, Li K. Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma. Front Mol Biosci 2022;9:843640. [DOI: 10.3389/fmolb.2022.843640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Bennedsen ALB, Furbo S, Bjarnsholt T, Raskov H, Gögenur I, Kvich L. The gut microbiota can orchestrate the signaling pathways in colorectal cancer. APMIS 2022;130:121-39. [PMID: 35007370 DOI: 10.1111/apm.13206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 41 |
Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI J 2022;21:162-82. [PMID: 35221839 DOI: 10.17179/excli2021-4456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 42 |
Martínez-Roca A, Giner-Calabuig M, Murcia O, Castillejo A, Soto JL, García-Heredia A, Jover R. Lynch-like Syndrome: Potential Mechanisms and Management. Cancers (Basel) 2022;14:1115. [PMID: 35267422 DOI: 10.3390/cancers14051115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 43 |
Xie J, Zhang Y, Jiang L. Role of Interleukin-1 in the pathogenesis of colorectal cancer: A brief look at anakinra therapy. Int Immunopharmacol 2022;105:108577. [PMID: 35121226 DOI: 10.1016/j.intimp.2022.108577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Symer M, Connolly J, Yeo H. Management of the Malignant Colorectal Polyp. Current Problems in Surgery 2022. [DOI: 10.1016/j.cpsurg.2022.101124] [Reference Citation Analysis]
|
| 45 |
Chen L, Jiang X, Zhang Q, Li Q, Zhang X, Zhang M, Yu Q, Gao D. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 46 |
Kim JC, Bodmer WF. Genomic landscape of colorectal carcinogenesis. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-021-03888-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Jin C, Zhu X, Huang X, Gong T, Wei Z, You J. Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis. J Comp Eff Res 2022. [PMID: 35023361 DOI: 10.2217/cer-2021-0134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Bergsland CH, Jeanmougin M, Moosavi SH, Svindland A, Bruun J, Nesbakken A, Sveen A, Lothe RA. Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer. Mod Pathol 2022;35:1236-46. [PMID: 35484226 DOI: 10.1038/s41379-022-01086-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Maratt JK, Stoffel E. Identification of Lynch Syndrome. Gastrointest Endosc Clin N Am 2022;32:45-58. [PMID: 34798986 DOI: 10.1016/j.giec.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 50 |
Liu Z, Tang H, Zhang W, Wang J, Wan L, Li X, Ji Y, Kong N, Zhang Y, Wang J, Fan Z, Guo Q. Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation. Aging (Albany NY) 2021;13:26161-79. [PMID: 34965217 DOI: 10.18632/aging.203804] [Reference Citation Analysis]
|
| 51 |
Chen K, Collins G, Wang H, Toh JWT. Pathological Features and Prognostication in Colorectal Cancer. Curr Oncol 2021;28:5356-83. [PMID: 34940086 DOI: 10.3390/curroncol28060447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Klein Kranenbarg RAM, Vali AH, IJzermans JNM, Pisanic TR 2nd, Wang TH, Azad N, Sukumar S, Fackler MJ. High performance methylated DNA markers for detection of colon adenocarcinoma. Clin Epigenetics 2021;13:218. [PMID: 34903270 DOI: 10.1186/s13148-021-01206-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Sanaei MJ, Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Shahrokh S, Zali MR, Bashash D. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. J Cell Physiol 2021. [PMID: 34897682 DOI: 10.1002/jcp.30655] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 54 |
Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Wu J, Ren X, Wang N, Zhou R, Chen M, Cai Y, Lin S, Zhang H, Xie X, Dang C, Zhang S, Zhou Z. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Front Genet 2021;12:779554. [PMID: 34880908 DOI: 10.3389/fgene.2021.779554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 56 |
Chen S, Li X, Zhang J, Li L, Wang X, Zhu Y, Guo L, Wang J. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer. J Gastrointest Oncol 2021;12:2157-71. [PMID: 34790382 DOI: 10.21037/jgo-21-494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 57 |
Alzahrani SM, Al Doghaither HA, Al-Ghafari AB. General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol 2021;15:271. [PMID: 34790355 DOI: 10.3892/mco.2021.2433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 58 |
Wen J, Wang Y, Yuan M, Huang Z, Zou Q, Pu Y, Zhao B, Cai Z. Role of mismatch repair in aging. Int J Biol Sci 2021;17:3923-35. [PMID: 34671209 DOI: 10.7150/ijbs.64953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 59 |
Miyashita N, Saito A. Organ Specificity and Heterogeneity of Cancer-Associated Fibroblasts in Colorectal Cancer. Int J Mol Sci 2021;22:10973. [PMID: 34681633 DOI: 10.3390/ijms222010973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Zhang J, Zhai J, Wong CC, Chen H, Wang X, Ji J, Yu J. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML). Oncogene 2021. [PMID: 34625711 DOI: 10.1038/s41388-021-01941-z] [Reference Citation Analysis]
|
| 61 |
Ilie DS, Mitroi G, Păun I, Ţenea-Cojan TŞ, Neamţu C, Totolici BD, Sapalidis K, Mogoantă SŞ, Murea A. Pathological and immunohistochemical study of colon cancer. Evaluation of markers for colon cancer stem cells. Rom J Morphol Embryol 2021;62:117-24. [PMID: 34609414 DOI: 10.47162/RJME.62.1.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 62 |
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen, Arunya Jiraviriyakul. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomed Rep 2021;15:86. [PMID: 34512974 DOI: 10.3892/br.2021.1462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 63 |
Duggan C, Yu M, Willbanks AR, Tapsoba JD, Wang CY, Grady WM, McTiernan A. Exercise effects on DNA methylation in EVL, CDKN2A (p14, ARF), and ESR1 in colon tissue from healthy men and women. Epigenetics 2021. [PMID: 34550860 DOI: 10.1080/15592294.2021.1982512] [Reference Citation Analysis]
|
| 64 |
Lawal B, Wang YC, Wu ATH, Huang HS. Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. Front Pharmacol 2021;12:691234. [PMID: 34512327 DOI: 10.3389/fphar.2021.691234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 65 |
Liu H, Ye Z, Yang T, Xie H, Duan T, Li M, Wu M, Song B. Predictive Value of Metabolic Parameters Derived From 18F-FDG PET/CT for Microsatellite Instability in Patients With Colorectal Carcinoma. Front Immunol 2021;12:724464. [PMID: 34512653 DOI: 10.3389/fimmu.2021.724464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 66 |
Miao YD, Mu LJ, Mi DH. Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. World J Gastrointest Oncol 2021; 13(8): 758-771 [PMID: 34457185 DOI: 10.4251/wjgo.v13.i8.758] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 67 |
Rasool M, Carracedo A, Sibiany A, Al-Sayes F, Karim S, Haque A, Natesan Pushparaj P, Asif M, Achakzai NM. Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients. Bioengineered 2021;12:5099-109. [PMID: 34369256 DOI: 10.1080/21655979.2021.1960715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 68 |
Sain A, Sahu S, Naskar D. Potential of olive oil and its phenolic compounds as therapeutic intervention against colorectal cancer: a comprehensive review. Br J Nutr 2021;:1-17. [PMID: 34338174 DOI: 10.1017/S0007114521002919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 69 |
Maratt JK, Rubenstein JH. Tailoring Colorectal Cancer Surveillance in Lynch Syndrome: More Is Not Always Better. Gastroenterology 2021;161:411-2. [PMID: 33961883 DOI: 10.1053/j.gastro.2021.04.069] [Reference Citation Analysis]
|
| 70 |
Hinoi T. Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants. J Anus Rectum Colon 2021;5:213-28. [PMID: 34395933 DOI: 10.23922/jarc.2021-009] [Reference Citation Analysis]
|
| 71 |
Lai WL, Lee SC, Chang KF, Huang XF, Li CY, Lee CJ, Wu CY, Hsu HJ, Tsai NM. Juniperus communis extract induces cell cycle arrest and apoptosis of colorectal adenocarcinoma in vitro and in vivo. Braz J Med Biol Res 2021;54:e10891. [PMID: 34287579 DOI: 10.1590/1414-431X2020e10891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Guo M, Wang SM. Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer. Front Cell Dev Biol 2021;9:701073. [PMID: 34322487 DOI: 10.3389/fcell.2021.701073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 73 |
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021;14:101174. [PMID: 34243011 DOI: 10.1016/j.tranon.2021.101174] [Cited by in Crossref: 171] [Cited by in F6Publishing: 216] [Article Influence: 85.5] [Reference Citation Analysis]
|
| 74 |
Yang YS, Wen D, Zhao XF. Transmembrane Protease TMPRSS4 Promotes the Formation and Development of Mismatch Repair Deficient Colon Cancer Liver Metastasis. Bull Exp Biol Med 2021;171:242-6. [PMID: 34173918 DOI: 10.1007/s10517-021-05203-6] [Reference Citation Analysis]
|
| 75 |
Tian T, Bi H, Zhang D, Liu Y, Sun H, Jia C, Zheng T, Huang H, Fu J, Zhu L, Zhao Y. Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk. Cancer Med 2021;10:4964-76. [PMID: 34145793 DOI: 10.1002/cam4.4056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 76 |
Jeong KY, Park M. Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatment. World J Gastrointest Oncol 2021;13:574-88. [PMID: 34163574 DOI: 10.4251/wjgo.v13.i6.574] [Reference Citation Analysis]
|
| 77 |
Jeong KY, Park M. Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatment. World J Gastrointest Oncol 2021; 13(6): 574-588 [PMID: 34163574 DOI: 10.4251/wjgo.v13.i6.574] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Li W, Li Q, Ge J, Wang Y, Li N, Lao Y, Wang Y, Liu K, Guo C, Lin W, Jiang G, Wei N, Wang C, Liu H, Wu J. Comprehensive Analysis of Differentially Expressed Long Noncoding RNA-mRNA in the Adenoma-Carcinoma Sequence of DNA Mismatch Repair Proficient Colon Cancer. J Oncol 2021;2021:9977695. [PMID: 34211553 DOI: 10.1155/2021/9977695] [Reference Citation Analysis]
|
| 79 |
Rizzo G, Bertotti A, Leto SM, Vetrano S. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer. J Exp Clin Cancer Res 2021;40:178. [PMID: 34074330 DOI: 10.1186/s13046-021-01970-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 80 |
Feng S, Liu J, Hailiang L, Wen J, Zhao Y, Li X, Lu G, Gao P, Zeng X. Amplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling. Transl Oncol 2021;14:101124. [PMID: 34049150 DOI: 10.1016/j.tranon.2021.101124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 81 |
Samanta A, Sarkar A. Altered expression of ERK, Cytochrome-c, and HSP70 triggers apoptosis in Quinacrine-exposed human invasive ductal carcinoma cells. Biomed Pharmacother 2021;139:111707. [PMID: 34243615 DOI: 10.1016/j.biopha.2021.111707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 82 |
Vuijk FA, van de Water C, Lent-van Vliet S, van der Valk MJM, Simmer F, van de Velde CJH, Vahrmeijer AL, Nagtegaal ID, Hilling DE. Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location. Cancers (Basel) 2021;13:2271. [PMID: 34065112 DOI: 10.3390/cancers13092271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Xu L, Lin Y, Chen X, Zheng L, Cheng Y, Hu J, Zheng B, Zhang B, Li G, Chi Z, Guo S, Liu D, He X, Lan P. A mutational signature for colorectal cancer prognosis prediction: Associated with immune cell infiltration. Clin Transl Med 2021;11:e414. [PMID: 34047467 DOI: 10.1002/ctm2.414] [Reference Citation Analysis]
|
| 84 |
Carethers JM. Racial and ethnic disparities in colorectal cancer incidence and mortality. Adv Cancer Res 2021;151:197-229. [PMID: 34148614 DOI: 10.1016/bs.acr.2021.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 85 |
Liebl MC, Hofmann TG. The Role of p53 Signaling in Colorectal Cancer. Cancers (Basel) 2021;13:2125. [PMID: 33924934 DOI: 10.3390/cancers13092125] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 86 |
Nagaraju GP, Kasa P, Dariya B, Surepalli N, Peela S, Ahmad S. Epigenetics and therapeutic targets in gastrointestinal malignancies. Drug Discov Today 2021:S1359-6446(21)00202-6. [PMID: 33895313 DOI: 10.1016/j.drudis.2021.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 87 |
Cheng Q, Wu Y, Xia H, Song X. RGL2 as an age-dependent factor regulates colon cancer progression. Comput Struct Biotechnol J 2021;19:2190-201. [PMID: 33995912 DOI: 10.1016/j.csbj.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Indukuri R, Jafferali MH, Song D, Damdimopoulos A, Hases L, Zhao C, Archer A, Williams C. Genome-wide estrogen receptor β chromatin binding in human colon cancer cells reveals its tumor suppressor activity. Int J Cancer 2021;149:692-706. [PMID: 33754337 DOI: 10.1002/ijc.33573] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 89 |
Baretti M, Karunasena E, Zahurak M, Walker R, Zhao Y, Pisanic TR 2nd, Wang TH, Greten TF, Duffy AG, Gootjes E, Meijer G, Verheul HMW, Ahuja N, Herman JG, Azad NS. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype. Clin Transl Sci 2021;14:954-63. [PMID: 33811727 DOI: 10.1111/cts.12960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 90 |
Hultcrantz R. Aspects of colorectal cancer screening, methods, age and gender. J Intern Med 2021;289:493-507. [PMID: 32929813 DOI: 10.1111/joim.13171] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 91 |
Huynh PK, Setty A, Phan H, Le TQ. Probabilistic domain-knowledge modeling of disorder pathogenesis for dynamics forecasting of acute onset. Artif Intell Med 2021;115:102056. [PMID: 34001316 DOI: 10.1016/j.artmed.2021.102056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 92 |
O'Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review. Cancers (Basel) 2021;13:1389. [PMID: 33808549 DOI: 10.3390/cancers13061389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 93 |
Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res 2021;151:425-68. [PMID: 34148620 DOI: 10.1016/bs.acr.2021.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 94 |
Iftekhar A, Berger H, Bouznad N, Heuberger J, Boccellato F, Dobrindt U, Hermeking H, Sigal M, Meyer TF. Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells. Nat Commun 2021;12:1003. [PMID: 33579932 DOI: 10.1038/s41467-021-21162-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 95 |
Ge S, Zhang Q, Chen Y, Tian Y, Yang R, Chen X, Li F, Zhang B. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicol Appl Pharmacol 2021;415:115450. [PMID: 33577917 DOI: 10.1016/j.taap.2021.115450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
AlMusawi S, Ahmed M, Nateri AS. Understanding cell-cell communication and signaling in the colorectal cancer microenvironment. Clin Transl Med 2021;11:e308. [PMID: 33635003 DOI: 10.1002/ctm2.308] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 97 |
Grady WM, Yu M, Markowitz SD. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021;160:690-709. [PMID: 33279516 DOI: 10.1053/j.gastro.2020.09.058] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 98 |
Biswas L, Tyc K, El Yakoubi W, Morgan K, Xing J, Schindler K. Meiosis interrupted: the genetics of female infertility via meiotic failure. Reproduction 2021;161:R13-35. [PMID: 33170803 DOI: 10.1530/REP-20-0422] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 99 |
Chen Q, Lei J, Zhou J, Ma S, Huang Q, Ge B. Chemopreventive effect of 4'-hydroxychalcone on intestinal tumorigenesis in ApcMin mice. Oncol Lett 2021;21:213. [PMID: 33510814 DOI: 10.3892/ol.2021.12474] [Reference Citation Analysis]
|
| 100 |
Xu Y, Li C, Zheng CZ, Zhang YQ, Guo TA, Liu FQ, Xu Y. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis. BMC Cancer 2021;21:45. [PMID: 33422027 DOI: 10.1186/s12885-020-07771-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 101 |
Ahmad R, Singh JK, Wunnava A, Al-Obeed O, Abdulla M, Srivastava SK. Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review). Int J Mol Med. 2021;47. [PMID: 33655327 DOI: 10.3892/ijmm.2021.4847] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 102 |
Dilek FH, Kahraman DİA. Histopathological Findings in Prophylactic Surgical Specimens. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_26] [Reference Citation Analysis]
|
| 103 |
Kirbiyik O, Özyilmaz B. Genetic Knowledge of Colorectal Cancer. Colon Polyps and Colorectal Cancer 2021. [DOI: 10.1007/978-3-030-57273-0_24] [Reference Citation Analysis]
|
| 104 |
Pal S, Garg M, Pandey AK. Biomarkers as Putative Therapeutic Targets in Colorectal Cancer. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-63369-1_8] [Reference Citation Analysis]
|
| 105 |
Ruiz-Bañobre J, Goel A. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Adv Cancer Res 2021;151:231-304. [PMID: 34148615 DOI: 10.1016/bs.acr.2021.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 106 |
Massaro C, Safadeh E, Sgueglia G, Stunnenberg HG, Altucci L, Dell'Aversana C. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance. Cells 2020;10:E39. [PMID: 33396628 DOI: 10.3390/cells10010039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 107 |
Maugeri A, Barchitta M, Magnano San Lio R, Li Destri G, Agodi A, Basile G. Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research. Int J Mol Sci 2020;22:E200. [PMID: 33379143 DOI: 10.3390/ijms22010200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 108 |
Luo XJ, Zhao Q, Liu J, Zheng JB, Qiu MZ, Ju HQ, Xu RH. Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer. Mol Ther 2021;29:587-96. [PMID: 33333293 DOI: 10.1016/j.ymthe.2020.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 109 |
Miao X, Xi Z, Zhang Y, Li Z, Huang L, Xin T, Shen R, Wang T. Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B. Dig Liver Dis 2020;52:1494-502. [PMID: 32807692 DOI: 10.1016/j.dld.2020.07.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 110 |
Ratnam NM, Frederico SC, Gonzalez JA, Gilbert MR. Clinical correlates for immune checkpoint therapy: significance for CNS malignancies. Neurooncol Adv 2021;3:vdaa161. [PMID: 33506203 DOI: 10.1093/noajnl/vdaa161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 111 |
Nguyen HT, Le DT, Duong QH, Tatipamula VB, Van Nguyen B. High frequency of microsatellite instability and its substantial co-existence with KRAS and BRAF mutations in Vietnamese patients with colorectal cancer. Oncol Lett 2021;21:41. [PMID: 33262833 DOI: 10.3892/ol.2020.12302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 112 |
Lee DW, Cho S, Shin A, Han SW, Kim TY. Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial. Sci Rep 2020;10:19467. [PMID: 33173165 DOI: 10.1038/s41598-020-76643-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Huang F, Peng Y, Ye Q, Chen J, Li Y, Liu S, Xu Y, Huang L. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study. World J Surg Oncol 2020;18:274. [PMID: 33099318 DOI: 10.1186/s12957-020-02049-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 114 |
Lim JH, Choi KH, Kim SY, Park CS, Kim SM, Park KC. Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis. Int J Mol Sci 2020;21:E7469. [PMID: 33050525 DOI: 10.3390/ijms21207469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 115 |
Rappaport JA, Waldman SA. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer. Expert Rev Clin Pharmacol 2020;13:1125-37. [PMID: 32945718 DOI: 10.1080/17512433.2020.1826304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 116 |
Wang X, Li T. Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer. Bioengineered 2020;11:165-74. [PMID: 32036725 DOI: 10.1080/21655979.2020.1718459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 117 |
Raeker MO, Carethers JM. Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer. J Cancer Immunol (Wilmington) 2020;2:116-27. [PMID: 33000102 DOI: 10.33696/cancerimmunol.2.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 118 |
Munakata K, Koi M, Kitajima T, Tseng-Rogenski S, Uemura M, Matsuno H, Kawai K, Sekido Y, Mizushima T, Toiyama Y, Yamada T, Mano M, Mita E, Kusunoki M, Mori M, Carethers JM. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement. Clin Transl Gastroenterol 2019;10:e00105. [PMID: 31789935 DOI: 10.14309/ctg.0000000000000105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 119 |
Sterlacci W, Vieth M. Serratierte Kolonpolypen. J Gastroenterol Hepatol Erkr 2020;18:64-71. [DOI: 10.1007/s41971-020-00077-3] [Reference Citation Analysis]
|
| 120 |
Liao C, Zhao J, Kumar S, Chakraborty C, Talluri S, Munshi NC, Shammas MA. RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells. Arch Clin Toxicol (Middlet) 2020;2:3-9. [PMID: 32968740 DOI: 10.46439/toxicology.2.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 121 |
Li JC, Chang X, Chen Y, Li XZ, Zhang XL, Yang SM, Hu CJ, Zhang H. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression. Curr Drug Targets 2019;20:1018-28. [PMID: 30827236 DOI: 10.2174/1389450120666190227184654] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 122 |
Mindiola-RomeroMD AE, GreenBS DC, Al-TurkmaniPhD MR, GodwinBS KN, MackayBS AC, TafeMD LJ, RenMD B, TsongalisPhD GJ. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues. Exp Mol Pathol 2020;116:104519. [PMID: 32822722 DOI: 10.1016/j.yexmp.2020.104519] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 123 |
Huang W, Li P, Qiu X. [A Literature Review on the Role of TBX5 in Expression and Progression of Lung Cancer: Current Perspectives]. Zhongguo Fei Ai Za Zhi 2020;23:883-8. [PMID: 32810974 DOI: 10.3779/j.issn.1009-3419.2020.102.27] [Reference Citation Analysis]
|
| 124 |
Xu Y, Huang Z, Li C, Zhu C, Zhang Y, Guo T, Liu F, Xu Y. Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes. Front Genet 2020;11:991. [PMID: 32973888 DOI: 10.3389/fgene.2020.00991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 125 |
Vatrano S, Pettinato A, Randazzo V, Zagami M, Agueli C, Cannella S, Banna GL, Fraggetta F, Santoro A. Diagnostic test assessment. Validation study of an alternative system to detect microsatellite instability in colorectal carcinoma. Pathologica 2020;112:178-83. [PMID: 32893846 DOI: 10.32074/1591-951X-113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 126 |
Onwuka JU, Li D, Liu Y, Huang H, Xu J, Liu Y, Zhang Y, Zhao Y. A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility. BMC Cancer 2020;20:692. [PMID: 32711505 DOI: 10.1186/s12885-020-07194-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 127 |
Jiang D, Shu C, Lei C, Wan Y, Sun L. Early-onset colorectal cancer: A distinct entity with unique genetic features. Oncol Lett 2020;20:33. [PMID: 32774506 DOI: 10.3892/ol.2020.11894] [Reference Citation Analysis]
|
| 128 |
Sugiyama T, Iwaizumi M, Kaneko M, Tani S, Yamade M, Hamaya Y, Furuta T, Miyajima H, Osawa S, Baba S, Maekawa M, Sugimoto K. DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection. Oncol Lett 2020;20:2435-41. [PMID: 32782560 DOI: 10.3892/ol.2020.11799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 129 |
Pan W, Wang W, Huang J, Lu K, Huang S, Jiang D, Bu D, Liu J, Jing H, Yao J, Hou Y. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer. Jpn J Clin Oncol 2020;50:446-55. [PMID: 32297641 DOI: 10.1093/jjco/hyz210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 130 |
Jalilvand A, Soltanpour MS. Promoter Hypermethylation of Wnt/β-catenin Signaling Pathway Inhibitor WIF-1 Gene and its Association with MTHFR C677T Polymorphism in Patients with Colorectal Cancer. Oman Med J 2020;35:e131. [PMID: 32607254 DOI: 10.5001/omj.2020.49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 131 |
Tseng-Rogenski SS, Munakata K, Choi DY, Martin PK, Mehta S, Koi M, Zheng W, Zhang Y, Carethers JM. The Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation. Mol Cell Biol 2020;40:e00029-20. [PMID: 32284349 DOI: 10.1128/MCB.00029-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 132 |
Liu C, Song C, Li J, Sun Q. CFTR Functions as a Tumor Suppressor and Is Regulated by DNA Methylation in Colorectal Cancer. Cancer Manag Res 2020;12:4261-70. [PMID: 32606923 DOI: 10.2147/CMAR.S248539] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 133 |
Pécriaux A, Favre L, Calderaro J, Charpy C, Derman J, Pujals A. Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA. J Clin Pathol 2021;74:36-42. [PMID: 32513848 DOI: 10.1136/jclinpath-2020-206581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 134 |
Zhao L, Shan G, Li L, Yu Y, Cheng G, Zheng X. A robust method for the rapid detection of microsatellite instability in colorectal cancer. Oncol Lett 2020;20:1982-8. [PMID: 32724444 DOI: 10.3892/ol.2020.11702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 135 |
Zajkowska M, Mroczko B. Eotaxins and Their Receptor in Colorectal Cancer-A Literature Review. Cancers (Basel) 2020;12:E1383. [PMID: 32481530 DOI: 10.3390/cancers12061383] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 136 |
Zhang X, Cheng J, He P, Zhu J, Chen Z, Miao S, Wang G, Jiang J, Wang Y. Active Monomer RTR-1 Derived from the Root of Rhodomyrtus t omentosa Induces Apoptosis in Gastric Carcinoma Cells by Inducing ER Stress and Inhibiting the STAT3 Signaling Pathway. Cancer Manag Res 2020;12:3117-29. [PMID: 32440210 DOI: 10.2147/CMAR.S237201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 137 |
Fan J, Li J, Guo S, Tao C, Zhang H, Wang W, Zhang Y, Zhang D, Ding S, Zeng C. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma. Clin Epigenetics 2020;12:56. [PMID: 32317010 DOI: 10.1186/s13148-020-00851-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 138 |
Liu X, Liu C, Chen C, Sun W, Ci Y, Li Q, Song Y. Combination of Inositol Hexaphosphate and Inositol Inhibits Liver Metastasis of Colorectal Cancer in Mice Through the Wnt/β-Catenin Pathway. Onco Targets Ther 2020;13:3223-35. [PMID: 32368081 DOI: 10.2147/OTT.S247646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 139 |
Carethers JM. High predictability for identifying Lynch syndrome via microsatellite instability testing or immunohistochemistry in all Lynch-associated tumor types. Transl Cancer Res 2019;8:S559-63. [PMID: 32266124 DOI: 10.21037/tcr.2019.08.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 140 |
Ma D, Chen X, Shen X, Sheng LQ, Liu XH. Binding patterns and structure–activity relationship of CDK8 inhibitors. Bioorganic Chemistry 2020;96:103624. [DOI: 10.1016/j.bioorg.2020.103624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 141 |
Nakanishi H, Sawada T, Kaizaki Y, Ota R, Suzuki H, Yamamoto E, Aoki H, Eizuka M, Hasatani K, Takahashi N, Inagaki S, Ebi M, Kato H, Kubota E, Kataoka H, Takahashi S, Tokino T, Minamoto T, Sugai T, Sasaki Y. Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum. PLoS One 2020;15:e0229262. [PMID: 32092099 DOI: 10.1371/journal.pone.0229262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 142 |
Samanta A, Ravindran G, Sarkar A. Quinacrine causes apoptosis in human cancer cell lines through caspase-mediated pathway and regulation of small-GTPase. J Biosci 2020;45. [DOI: 10.1007/s12038-020-0011-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 143 |
Hofmanová J, Slavík J, Ovesná P, Tylichová Z, Dušek L, Straková N, Vaculová AH, Ciganek M, Kala Z, Jíra M, Penka I, Kyclová J, Kolář Z, Kozubík A, Machala M, Vondráček J. Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples. PLoS One 2020;15:e0228010. [PMID: 31999740 DOI: 10.1371/journal.pone.0228010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 144 |
Lawrence GW, Begley M, Cotter PD, Guinane CM. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa. Int J Mol Sci 2020;21:E924. [PMID: 32019270 DOI: 10.3390/ijms21030924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 145 |
Raeker MÖ, Pierre-Charles J, Carethers JM. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels. Cell Mol Gastroenterol Hepatol 2020;9:689-704. [PMID: 31982570 DOI: 10.1016/j.jcmgh.2020.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 146 |
Carethers JM, Doubeni CA. Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. Gastroenterology 2020;158:354-67. [PMID: 31682851 DOI: 10.1053/j.gastro.2019.10.029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 27.7] [Reference Citation Analysis]
|
| 147 |
Nguyen LH, Goel A, Chung DC. Pathways of Colorectal Carcinogenesis. Gastroenterology 2020;158:291-302. [PMID: 31622622 DOI: 10.1053/j.gastro.2019.08.059] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 46.7] [Reference Citation Analysis]
|
| 148 |
Kastrinos F, Samadder NJ, Burt RW. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer. Gastroenterology 2020;158:389-403. [PMID: 31759928 DOI: 10.1053/j.gastro.2019.11.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 149 |
Wang D, Zhao R, Qu YY, Mei XY, Zhang X, Zhou Q, Li Y, Yang SB, Zuo ZG, Chen YM, Lin Y, Xu W, Chen C, Zhao SM, Zhao JY. Colonic Lysine Homocysteinylation Induced by High-Fat Diet Suppresses DNA Damage Repair. Cell Rep 2018;25:398-412.e6. [PMID: 30304680 DOI: 10.1016/j.celrep.2018.09.022] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 150 |
Yang C, Zhang Y, Xu X, Li W. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients. Aging (Albany NY) 2019;11:11880-92. [PMID: 31852837 DOI: 10.18632/aging.102492] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 151 |
Paredes SR, Chan C, Rickard MJFX. Immunohistochemistry in screening for heritable colorectal cancer: what to do with an abnormal result. ANZ J Surg 2020;90:702-7. [PMID: 31828933 DOI: 10.1111/ans.15586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 152 |
Kurbatov V, Khan SA. Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST). Ann Surg Oncol 2020;27:973-4. [PMID: 31788754 DOI: 10.1245/s10434-019-08051-x] [Reference Citation Analysis]
|
| 153 |
Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 2019;16:713-32. [PMID: 31455888 DOI: 10.1038/s41575-019-0189-8] [Cited by in Crossref: 777] [Cited by in F6Publishing: 776] [Article Influence: 194.3] [Reference Citation Analysis]
|
| 154 |
Zhang X, Cheng J, He P, Zhu J, Chen Z, Miao S, Wang G, Jiang J, Wang Y. Active monomer RTR-1 derived from the root of Rhodomyrtus tomentosa induces apoptosis in gastric carcinoma cells by inducing ER stress and inhibiting the STAT3 signalling pathway.. [DOI: 10.1101/860130] [Reference Citation Analysis]
|
| 155 |
Guo J, Yang Z, Zhou H, Yue J, Mu T, Zhang Q, Bi X. Upregulation of DKK3 by miR‐483‐3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins. Mol Carcinog 2019;59:168-78. [DOI: 10.1002/mc.23138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 156 |
Muller C, Matthews L, Kupfer SS, Weiss JM. Effective Identification of Lynch Syndrome in Gastroenterology Practice. Curr Treat Options Gastroenterol 2019;17:666-80. [PMID: 31677041 DOI: 10.1007/s11938-019-00261-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 157 |
Borchiellini M, Ummarino S, Di Ruscio A. The Bright and Dark Side of DNA Methylation: A Matter of Balance. Cells 2019;8:E1243. [PMID: 31614870 DOI: 10.3390/cells8101243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 158 |
Loktionov A, Soubieres A, Bandaletova T, Mathur J, Poullis A. Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers. Eur J Gastroenterol Hepatol 2019;31:1220-7. [PMID: 31498281 DOI: 10.1097/MEG.0000000000001535] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 159 |
Liu GC, Liu RY, Yan JP, An X, Jiang W, Ling YH, Chen JW, Bei JX, Zuo XY, Cai MY, Liu ZX, Zuo ZX, Liu JH, Pan ZZ, Ding PR. The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers. J Natl Cancer Inst 2018;110:975-84. [PMID: 29471527 DOI: 10.1093/jnci/djy004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 160 |
Ali Koc M, Utku Celik S, Akyol C. Colon Cancer. In: Streba L, Ionut Gheonea D, Schenker M, editors. Current Trends in Cancer Management. IntechOpen; 2019. [DOI: 10.5772/intechopen.81597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 161 |
Yuan F, Xiao X, Che G, Wang Y, Wang T, Luo X, Liang W, Gao L, Zhang L. A functional variant in the flanking region of pri-let-7f contributes to colorectal cancer risk in a Chinese population. J Cell Physiol 2019;234:15717-25. [PMID: 30740676 DOI: 10.1002/jcp.28227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 162 |
Ying X, Pan R, Zhong J, Wu B, Jiang Y, Ying J, Zhou C, Dai J, Zhao S, Shen Y, Zhang W, Duan S. Significant association of EED promoter hypomethylation with colorectal cancer. Oncol Lett 2019;18:1564-70. [PMID: 31423224 DOI: 10.3892/ol.2019.10432] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 163 |
Sethi N, Kikuchi O, McFarland J, Zhang Y, Chung M, Kafker N, Islam M, Lampson B, Chakraborty A, Kaelin WG Jr, Bass AJ. Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma. JCI Insight 2019;4:128439. [PMID: 31391338 DOI: 10.1172/jci.insight.128439] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 164 |
Wilson MR, Jiang Y, Villalta PW, Stornetta A, Boudreau PD, Carrá A, Brennan CA, Chun E, Ngo L, Samson LD, Engelward BP, Garrett WS, Balbo S, Balskus EP. The human gut bacterial genotoxin colibactin alkylates DNA. Science 2019;363:eaar7785. [PMID: 30765538 DOI: 10.1126/science.aar7785] [Cited by in Crossref: 269] [Cited by in F6Publishing: 267] [Article Influence: 67.3] [Reference Citation Analysis]
|
| 165 |
Gupta R, Bhatt LK, Momin M. Potent antitumor activity of Laccaic acid and Phenethyl isothiocyanate combination in colorectal cancer via dual inhibition of DNA methyltransferase-1 and Histone deacetylase-1. Toxicology and Applied Pharmacology 2019;377:114631. [DOI: 10.1016/j.taap.2019.114631] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 166 |
Bhattacharya I, Barman N, Maiti M, Sarkar R. Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma. Med Pharm Rep 2019;92:246-52. [PMID: 31460505 DOI: 10.15386/mpr-1218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 167 |
De Palma FDE, D'Argenio V, Pol J, Kroemer G, Maiuri MC, Salvatore F. The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. Cancers (Basel). 2019;11. [PMID: 31330830 DOI: 10.3390/cancers11071017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 168 |
Guo G, Wang Y, Zhou Y, Quan Q, Zhang Y, Wang H, Zhang B, Xia L. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J Immunother Cancer 2019;7:179. [PMID: 31300050 DOI: 10.1186/s40425-019-0656-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 169 |
Sveen A, Kopetz S, Lothe RA. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol 2020;17:11-32. [PMID: 31289352 DOI: 10.1038/s41571-019-0241-1] [Cited by in Crossref: 130] [Cited by in F6Publishing: 137] [Article Influence: 32.5] [Reference Citation Analysis]
|
| 170 |
Xie W, Wei L, Guo J, Guo H, Song X, Sheng X. Physiological functions of Wilms' tumor 1-associating protein and its role in tumourigenesis. J Cell Biochem 2019;120:10884-92. [PMID: 30756410 DOI: 10.1002/jcb.28402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 171 |
Li X, Xu J, Li L, Mu X, Wang Y, Li X. Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer. Clin Colorectal Cancer 2019;18:e316-23. [PMID: 31375292 DOI: 10.1016/j.clcc.2019.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 172 |
Yousefi B, Mohammadlou M, Abdollahi M, Salek Farrokhi A, Karbalaei M, Keikha M, Kokhaei P, Valizadeh S, Rezaiemanesh A, Arabkari V, Eslami M. Epigenetic changes in gastric cancer induction by Helicobacter pylori. J Cell Physiol 2019;234:21770-84. [DOI: 10.1002/jcp.28925] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 173 |
Ham-Karim HA, Ebili HO, Bradshaw K, Richman SD, Fadhil W, Domingo E, Tomlinson I, Ilyas M. Targeted next generation sequencing reveals a common genetic pathway for colorectal cancers with chromosomal instability and those with microsatellite and chromosome stability. Pathol Res Pract 2019;215:152445. [PMID: 31153694 DOI: 10.1016/j.prp.2019.152445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 174 |
Bi H, Liu Y, Tian T, Xia T, Pu R, Zhang Y, Hu F, Zhao Y. A Propensity Score-adjusted Analysis of the Effects of Ubiquitin E3 Ligase Copy Number Variation in Peripheral Blood Leukocytes on Colorectal Cancer Risk. J Cancer 2019;10:3291-302. [PMID: 31289601 DOI: 10.7150/jca.29872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 175 |
Zhao Y, Ge X, He J, Cheng Y, Wang Z, Wang J, Sun L. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World J Surg Oncol 2019;17:85. [PMID: 31118034 DOI: 10.1186/s12957-019-1621-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 176 |
Bazzichetto C, Conciatori F, Falcone I, Cognetti F, Milella M, Ciuffreda L. Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer. J Oncol 2019;2019:5373580. [PMID: 31191652 DOI: 10.1155/2019/5373580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 177 |
Troncone E, Monteleone G. Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword. Cancers (Basel) 2019;11:E612. [PMID: 31052449 DOI: 10.3390/cancers11050612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 178 |
Igder S, Mohammadiasl J, Mokarram P. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions. Biochem Genet 2019;57:767-80. [PMID: 30997628 DOI: 10.1007/s10528-019-09918-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 179 |
Hauptman N, Jevšinek Skok D, Spasovska E, Boštjančič E, Glavač D. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer. BMC Med Genomics 2019;12:54. [PMID: 30987631 DOI: 10.1186/s12920-019-0501-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 180 |
Keum N, Liu L, Hamada T, Qian ZR, Nowak JA, Cao Y, da Silva A, Kosumi K, Song M, Nevo D, Wang M, Chan AT, Meyerhardt JA, Fuchs CS, Wu K, Ogino S, Nishihara R, Zhang X. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics. Cancer Causes Control 2019;30:637-49. [PMID: 30963391 DOI: 10.1007/s10552-019-01165-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 181 |
Reynolds IS, Furney SJ, Kay EW, McNamara DA, Prehn JHM, Burke JP. Meta-analysis of the molecular associations of mucinous colorectal cancer. Br J Surg 2019;106:682-91. [PMID: 30945755 DOI: 10.1002/bjs.11142] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 182 |
Zhang K, Yan J, Yi B, Rui Y, Hu H. High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma. Future Oncol 2019;15:1085-95. [PMID: 30932685 DOI: 10.2217/fon-2018-0499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 183 |
Yuan S, Li L, Xiang S, Jia H, Luo T. Cadherin-11 is inactivated due to promoter methylation and functions in colorectal cancer as a tumour suppressor. Cancer Manag Res 2019;11:2517-29. [PMID: 31114321 DOI: 10.2147/CMAR.S193921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 184 |
Breininger SP, Malcomson FC, Afshar S, Turnbull DM, Greaves L, Mathers JC. Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk. Proc Nutr Soc 2019;78:426-37. [PMID: 30898183 DOI: 10.1017/S0029665119000533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 185 |
Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, Martins SF, Baltazar F, Rodrigues LR. Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display. Sci Rep 2019;9:3958. [PMID: 30850705 DOI: 10.1038/s41598-019-40562-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 186 |
Erkekoglu P. Introductory Chapter: Interactions between Environmental Chemicals and KRAS Oncogene in Different Cancers - Special Focus on Colorectal, Pancreatic, and Lung Cancers. Oncogenes and Carcinogenesis 2019. [DOI: 10.5772/intechopen.82459] [Reference Citation Analysis]
|
| 187 |
Yu M, Maden SK, Stachler M, Kaz AM, Ayers J, Guo Y, Carter KT, Willbanks A, Heinzerling TJ, O'Leary RM, Xu X, Bass A, Chandar AK, Chak A, Elliott R, Willis JE, Markowitz SD, Grady WM. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut 2019;68:389-99. [PMID: 29884612 DOI: 10.1136/gutjnl-2017-314544] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 188 |
Nakano K, Yamamoto H, Fujiwara M, Koga Y, Tsuruta S, Ihara E, Oki E, Nakamura M, Ogawa Y, Oda Y. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency. Am J Surg Pathol 2018;42:172-82. [PMID: 28877066 DOI: 10.1097/PAS.0000000000000947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 189 |
He H, Zhao X, Zhu Z, Du L, Chen E, Liu S, Li Q, Dong J, Yang J, Lei L. MicroRNA-3191 promotes migration and invasion by downregulating TGFBR2 in colorectal cancer. J Biochem Mol Toxicol 2019;33:e22308. [PMID: 30770602 DOI: 10.1002/jbt.22308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 190 |
Yaghoubi N, Soltani A, Ghazvini K, Hassanian SM, Hashemy SI. PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer. Biomedicine & Pharmacotherapy 2019;110:312-8. [DOI: 10.1016/j.biopha.2018.11.105] [Cited by in Crossref: 138] [Cited by in F6Publishing: 146] [Article Influence: 34.5] [Reference Citation Analysis]
|
| 191 |
Yu Y, Ying J, Zhang W, Li W, Sun Y, Yang L, Cui C, Zeng Y, Zhou A. Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study. Asia Pac J Clin Oncol 2019;15:128-35. [PMID: 30693649 DOI: 10.1111/ajco.13130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 192 |
Short E, Sampson J. The role of inherited genetic variants in colorectal polyposis syndromes. Adv Genet 2019;103:183-217. [PMID: 30904095 DOI: 10.1016/bs.adgen.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 193 |
Sriramulu S, Ramachandran M, Subramanian S, Kannan R, Gopinath M, Sollano J, Bissi L, Banerjee A, Marotta F, Pathak S. A review on role of ATM gene in hereditary transfer of colorectal cancer. Acta Biomed 2019;89:463-9. [PMID: 30657113 DOI: 10.23750/abm.v89i4.6095] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 194 |
Polyzos KA, Karadima ML, Kosma AC, Lazaris A, Kavantzas N, Tsavaris N. Clinical Influence of Ploidy and Cancer Stem Cells and Other Parameters in Stage IV Colorectal Cancer. In Vivo 2019;33:245-9. [PMID: 30587631 DOI: 10.21873/invivo.11467] [Reference Citation Analysis]
|
| 195 |
Yamaura T, Miyoshi H, Maekawa H, Morimoto T, Yamamoto T, Kakizaki F, Higasa K, Kawada K, Matsuda F, Sakai Y, Taketo MM. Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells. Oncotarget 2018;9:37534-48. [PMID: 30680068 DOI: 10.18632/oncotarget.26495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 196 |
Xi M, Chen T, Wu C, Gao X, Wu Y, Luo X, Du K, Yu L, Cai T, Shen R, Sun H. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors. Eur J Med Chem 2019;164:77-91. [PMID: 30594029 DOI: 10.1016/j.ejmech.2018.11.076] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 197 |
Mori T, Hamaya Y, Uotani T, Yamade M, Iwaizumi M, Furuta T, Miyajima H, Osawa S, Sugimoto K. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma. PLoS One 2018;13:e0208557. [PMID: 30532127 DOI: 10.1371/journal.pone.0208557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 198 |
Lao Y, Li Q, Li N, Liu H, Liu K, Jiang G, Wei N, Wang C, Wang Y, Wu J. Long noncoding RNA ENST00000455974 plays an oncogenic role through up-regulating JAG2 in human DNA mismatch repair-proficient colon cancer. Biochem Biophys Res Commun. 2019;508:339-347. [PMID: 30473216 DOI: 10.1016/j.bbrc.2018.11.088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 199 |
Molinari C, Marisi G, Passardi A, Matteucci L, De Maio G, Ulivi P. Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine? Int J Mol Sci 2018;19:E3733. [PMID: 30477151 DOI: 10.3390/ijms19123733] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 20.6] [Reference Citation Analysis]
|
| 200 |
Carethers JM. Clinical and Genetic Factors to Inform Reducing Colorectal Cancer Disparitites in African Americans. Front Oncol. 2018;8:531. [PMID: 30524961 DOI: 10.3389/fonc.2018.00531] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 201 |
Kelley KA, Wieghard N, Chin Y, Potter A, Mori M, Wong MH, Chin K, Tsikitis VL. MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis. Dis Colon Rectum 2018;61:1290-6. [PMID: 30239392 DOI: 10.1097/DCR.0000000000001192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 202 |
Lu JW, Raghuram D, Fong PA, Gong Z. Inducible Intestine-Specific Expression of krasV12 Triggers Intestinal Tumorigenesis In Transgenic Zebrafish. Neoplasia 2018;20:1187-97. [PMID: 30390498 DOI: 10.1016/j.neo.2018.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 203 |
Salman P, Panay S, Fernández R, Mahave M, Soza-Ried C. Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer. Onco Targets Ther 2018;11:7295-300. [PMID: 30425520 DOI: 10.2147/OTT.S167645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 204 |
Liang J, Zhou W, Sakre N, DeVecchio J, Ferrandon S, Ting AH, Bao S, Bissett I, Church J, Kalady MF. Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers. Br J Cancer 2018;119:1267-77. [PMID: 30318507 DOI: 10.1038/s41416-018-0249-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 205 |
Carethers JM. Risk factors for colon location of cancer. Transl Gastroenterol Hepatol 2018;3:76. [PMID: 30505963 DOI: 10.21037/tgh.2018.09.15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 206 |
Ahmed I, Umar S. Microbiome and Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:217-25. [PMID: 33456404 DOI: 10.1007/s11888-018-0416-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 207 |
Gao HL, Wang X, Sun HR, Zhou JD, Lin SQ, Xing YH, Zhu L, Zhou HB, Zhao YS, Chi Q, Liu YP. Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China. Gut Liver 2018;12:173-82. [PMID: 29291617 DOI: 10.5009/gnl17163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 208 |
Takane K, Fukuyo M, Matsusaka K, Ota S, Rahmutulla B, Matsushita K, Miyauchi H, Nakatani Y, Matsubara H, Kaneda A. The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis. Oncotarget 2018;9:32653-66. [PMID: 30220972 DOI: 10.18632/oncotarget.25987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 209 |
Lin LC, Kuo TT, Chang HY, Liu WS, Hsia SM, Huang TC. Manzamine A Exerts Anticancer Activity against Human Colorectal Cancer Cells. Mar Drugs 2018;16:E252. [PMID: 30060617 DOI: 10.3390/md16080252] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 210 |
Gao G, Bian Y, Qian H, Yang M, Hu J, Li L, Yu L, Liu B, Qian X. Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog. Exp Ther Med 2018;16:1758-65. [PMID: 30186399 DOI: 10.3892/etm.2018.6421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 211 |
Yun KE, Chang Y, Rampal S, Zhang Y, Cho J, Jung HS, Kim CW, Jeong C, Cainzos-Achirica M, Zhao D, Pastor-Barriuso R, Shin H, Guallar E, Ryu S. Coexistence of Colorectal Adenomas and Coronary Calcification in Asymptomatic Men and Women. J Clin Gastroenterol 2018;52:508-14. [PMID: 28471937 DOI: 10.1097/MCG.0000000000000824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 212 |
Young S, Golzarian J. Primary Tumor Location in Colorectal Cancer: Comparison of Right- and Left-Sided Colorectal Cancer Characteristics for the Interventional Radiologist. Cardiovasc Intervent Radiol 2018;41:1819-25. [PMID: 29946943 DOI: 10.1007/s00270-018-2014-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 213 |
Eto T, Miyake K, Nosho K, Ohmuraya M, Imamura Y, Arima K, Kanno S, Fu L, Kiyozumi Y, Izumi D, Sugihara H, Hiyoshi Y, Miyamoto Y, Sawayama H, Iwatsuki M, Baba Y, Yoshida N, Furukawa T, Araki K, Baba H, Ishimoto T. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression: Impact of RNF43 mutations on colorectal cancer progression. J Pathol 2018;245:445-55. [DOI: 10.1002/path.5098] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 214 |
Vicente CM, da Silva DA, Sartorio PV, Silva TD, Saad SS, Nader HB, Forones NM, Toma L. Heparan Sulfate Proteoglycans in Human Colorectal Cancer. Anal Cell Pathol (Amst) 2018;2018:8389595. [PMID: 30027065 DOI: 10.1155/2018/8389595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 215 |
Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A, Clerico G, Reginelli A, Giuliani A, Sciaudone G, Kontovounisios C, Brunese L, Trompetto M, Selvaggi F. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract. 2018;2018:2397863. [PMID: 30008744 DOI: 10.1155/2018/2397863] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 216 |
Alizadeh Naini M, Kavousipour S, Hasanzarini M, Nasrollah A, Monabati A, Mokarram P. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer. Asian Pac J Cancer Prev. 2018;19:1223-1227. [PMID: 29801405 DOI: 10.22034/apjcp.2018.19.5.1223] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 217 |
Kuan TC, Lin PC, Yang SH, Lin CC, Lan YT, Lin HH, Liang WY, Chen WS, Lin JK, Jiang JK, Chang SC. Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients. PLoS One 2018;13:e0197681. [PMID: 29795620 DOI: 10.1371/journal.pone.0197681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 218 |
Qiu X, Feng JR, Qiu J, Liu L, Xie Y, Zhang YP, Liu J, Zhao Q. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer. Biomed Pharmacother 2018;104:172-80. [PMID: 29772438 DOI: 10.1016/j.biopha.2018.05.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 219 |
Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (review). Oncol Lett. 2018;16:9-18. [PMID: 29928381 DOI: 10.3892/ol.2018.8679] [Cited by in Crossref: 68] [Cited by in F6Publishing: 93] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 220 |
Zhou G, Noordam L, Sprengers D, Doukas M, Boor PPC, van Beek AA, Erkens R, Mancham S, Grünhagen D, Menon AG, Lange JF, Burger PJWA, Brandt A, Galjart B, Verhoef C, Kwekkeboom J, Bruno MJ. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. Oncoimmunology 2018;7:e1448332. [PMID: 29900067 DOI: 10.1080/2162402X.2018.1448332] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 221 |
Peng J, Huang D, Poston G, Ma X, Wang R, Sheng W, Zhou X, Zhu X, Cai S. The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients. Oncotarget 2017;8:49076-83. [PMID: 28416767 DOI: 10.18632/oncotarget.16176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 222 |
Taye N, Alam A, Ghorai S, Chatterji DG, Parulekar A, Mogare D, Singh S, Sengupta P, Chatterjee S, Bhat MK, Santra MK, Salunkhe PB, Finston SK, Chattopadhyay S. SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression. Oncotarget 2018;9:21322-36. [PMID: 29765542 DOI: 10.18632/oncotarget.25093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 223 |
Vaccaro CA, Piñero T, Herrando AI, Cajal R, Ferro A, Kalfayan P, Santino JP, Falconi MD, Verzura A, Guerrero G, Riggi MC, Pavicic W, González ML. Síndrome de Lynch: impacto de la caracterización de familias en base a estudios genéticos. RevOnco 2018;23. [DOI: 10.56969/oc.v23i1.63] [Reference Citation Analysis]
|
| 224 |
Sun R, Chen P, Li L, Sun H, Nie X, Liang Y, Yuan F, Pu Y, Bai P, Zhang L, Gao L. A polymorphism rs4705341 in the flanking region of miR-143/145 predicts risk and prognosis of colorectal cancer. Oncotarget 2016;7:62084-90. [PMID: 27556691 DOI: 10.18632/oncotarget.11387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 225 |
Margetis N, Kouloukoussa M, Pavlou K, Vrakas S, Mariolis-Sapsakos T. K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas. In Vivo 2017;31:527-42. [PMID: 28652417 DOI: 10.21873/invivo.11091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 226 |
Porru M, Pompili L, Caruso C, Biroccio A, Leonetti C. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities. J Exp Clin Cancer Res. 2018;37:57. [PMID: 29534749 DOI: 10.1186/s13046-018-0719-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 227 |
Baretti M, Azad NS. The role of epigenetic therapies in colorectal cancer. Curr Probl Cancer. 2018;42:530-547. [PMID: 29625794 DOI: 10.1016/j.currproblcancer.2018.03.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 228 |
Gong Q, Zhang HH, Sun SB, Ge WM, Li Y, Zhu YC, Li LP. Mismatch repair-deficient status associates with favorable prognosis of Eastern Chinese population with sporadic colorectal cancer. Oncol Lett 2018;15:7007-13. [PMID: 29725427 DOI: 10.3892/ol.2018.8192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 229 |
Zhu L, Huang Y, Fang X, Liu C, Deng W, Zhong C, Xu J, Xu D, Yuan Y. A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing. The Journal of Molecular Diagnostics 2018;20:225-31. [DOI: 10.1016/j.jmoldx.2017.11.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 230 |
Ashktorab H, Mokarram P, Azimi H, Olumi H, Varma S, Nickerson ML, Brim H. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer. Oncotarget 2017;8:7852-66. [PMID: 28002797 DOI: 10.18632/oncotarget.13977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 231 |
Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance. Oncotarget 2017;8:7025-38. [PMID: 27705923 DOI: 10.18632/oncotarget.12347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 232 |
Takane K, Matsusaka K, Ota S, Fukuyo M, Yue Y, Nishimura M, Sakai E, Matsushita K, Miyauchi H, Aburatani H, Nakatani Y, Takayama T, Matsubara H, Akagi K, Kaneda A. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis. Oncotarget 2016;7:84003-16. [PMID: 27563825 DOI: 10.18632/oncotarget.11510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 233 |
Romano G, Chagani S, Kwong LN. The path to metastatic mouse models of colorectal cancer. Oncogene 2018;37:2481-9. [DOI: 10.1038/s41388-018-0155-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 234 |
Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation. Mol Oncol 2018;12:391-405. [PMID: 29360267 DOI: 10.1002/1878-0261.12173] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 235 |
Barták BK, Kalmár A, Galamb O, Wichmann B, Nagy ZB, Tulassay Z, Dank M, Igaz P, Molnár B. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection. Pathol Oncol Res 2019;25:915-23. [DOI: 10.1007/s12253-018-0382-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 236 |
Sawada T, Yamamoto E, Yamano HO, Nojima M, Harada T, Maruyama R, Ashida M, Aoki H, Matsushita HO, Yoshikawa K, Harada E, Tanaka Y, Wakita S, Niinuma T, Kai M, Eizuka M, Sugai T, Suzuki H. Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations. Oncotarget 2016;7:35106-18. [PMID: 27145369 DOI: 10.18632/oncotarget.9044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 237 |
Rashid MU, Hussain I, Jehanzeb S, Ali S, Jain AG, Kumar R, Khetpal N, Ahmad S. Functional Consequences and Clinical Significance of Tyrosine Kinase Inhibitors in Advanced Colorectal Cancer. Role of Tyrosine Kinases in Gastrointestinal Malignancies 2018. [DOI: 10.1007/978-981-13-1486-5_10] [Reference Citation Analysis]
|
| 238 |
Smith L, Anti S, White N, Saldanha SN. The Genetics and Epigenetics of Colorectal Cancer Health Disparity. Epigenetic Mechanisms in Cancer 2018. [DOI: 10.1016/b978-0-12-809552-2.00004-8] [Reference Citation Analysis]
|
| 239 |
Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Dig Dis Sci 2018;63:1123-38. [PMID: 29572615 DOI: 10.1007/s10620-018-5000-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 240 |
Chae YK, Taxter TJ, Cavalcante LL, Giles FJ. Immunotherapeutic Biomarkers and Selection Strategies. Early Phase Cancer Immunotherapy 2018. [DOI: 10.1007/978-3-319-63757-0_3] [Reference Citation Analysis]
|
| 241 |
Yang VW. The Cell Cycle. Physiology of the Gastrointestinal Tract 2018. [DOI: 10.1016/b978-0-12-809954-4.00008-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 242 |
Barnett RM, Borras E, Jewel Samadder N, Vilar E. Chemoprevention in Hereditary Colorectal Cancer Syndromes. Hereditary Colorectal Cancer 2018. [DOI: 10.1007/978-3-319-74259-5_22] [Reference Citation Analysis]
|
| 243 |
Clarke CN, Scott Kopetz E. Molecular Markers and Mutational Analysis. Rectal Cancer 2018. [DOI: 10.1007/978-3-319-16384-0_19] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 244 |
Kim JH, Bae JM, Cho NY, Kang GH. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Oncotarget. 2016;7:14095-14111. [PMID: 26883113 DOI: 10.18632/oncotarget.7374] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 245 |
Qiu X, Feng JR, Wang F, Chen PF, Chen XX, Zhou R, Chang Y, Liu J, Zhao Q. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer. Mol Med Rep 2018;17:3028-34. [PMID: 29257257 DOI: 10.3892/mmr.2017.8210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 246 |
Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. Mediterranean Diet: Prevention of Colorectal Cancer. Front Nutr. 2017;4:59. [PMID: 29259973 DOI: 10.3389/fnut.2017.00059] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 247 |
Horpaopan S, Kirfel J, Peters S, Kloth M, Hüneburg R, Altmüller J, Drichel D, Odenthal M, Kristiansen G, Strassburg C, Nattermann J, Hoffmann P, Nürnberg P, Büttner R, Thiele H, Kahl P, Spier I, Aretz S. Exome sequencing characterizes the somatic mutation spectrum of early serrated lesions in a patient with serrated polyposis syndrome (SPS). Hered Cancer Clin Pract 2017;15:22. [PMID: 29213343 DOI: 10.1186/s13053-017-0082-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 248 |
Shin D, Lee J, Gong JR, Cho KH. Percolation transition of cooperative mutational effects in colorectal tumorigenesis. Nat Commun 2017;8:1270. [PMID: 29097710 DOI: 10.1038/s41467-017-01171-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 249 |
Prenner S, Levitsky J. Comprehensive Review on Colorectal Cancer and Transplant. Am J Transplant 2017;17:2761-74. [PMID: 28471512 DOI: 10.1111/ajt.14340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 250 |
Ashktorab H, Kupfer SS, Brim H, Carethers JM. Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology 2017;153:910-23. [PMID: 28807841 DOI: 10.1053/j.gastro.2017.08.018] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 251 |
Ma J, Zhang S, Hu Y, Li X, Yuan F, Sun D, Wang L, Zhang F, Chen G, Cui P. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer. Medicine (Baltimore) 2017;96:e7011. [PMID: 29049167 DOI: 10.1097/MD.0000000000007011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 252 |
Fagunwa IO, Loughrey MB, Coleman HG. Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms. Best Pract Res Clin Gastroenterol 2017;31:561-8. [PMID: 29195676 DOI: 10.1016/j.bpg.2017.09.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 253 |
Juárez M, Egoavil C, Rodríguez-Soler M, Hernández-Illán E, Guarinos C, García-Martínez A, Alenda C, Giner-Calabuig M, Murcia O, Mangas C, Payá A, Aparicio JR, Ruiz FA, Martínez J, Casellas JA, Soto JL, Zapater P, Jover R. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia. PLoS One 2017;12:e0184937. [PMID: 28953955 DOI: 10.1371/journal.pone.0184937] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 254 |
Zarkavelis G, Boussios S, Papadaki A, Katsanos KH, Christodoulou DK, Pentheroudakis G. Current and future biomarkers in colorectal cancer. Ann Gastroenterol 2017;30:613-21. [PMID: 29118555 DOI: 10.20524/aog.2017.0191] [Cited by in Crossref: 35] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 255 |
Puccini A, Berger MD, Naseem M, Tokunaga R, Battaglin F, Cao S, Hanna DL, McSkane M, Soni S, Zhang W, Lenz HJ. Colorectal cancer: epigenetic alterations and their clinical implications. Biochim Biophys Acta Rev Cancer. 2017;1868:439-448. [PMID: 28939182 DOI: 10.1016/j.bbcan.2017.09.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 256 |
Yang Y, Junjie P, Sanjun C, Ma Y. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. J Cancer. 2017;8:3212-3225. [PMID: 29158793 DOI: 10.7150/jca.19794] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 257 |
Koi M, Carethers JM. The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncol. 2017;13:1633-1647. [PMID: 28829193 DOI: 10.2217/fon-2017-0145] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 258 |
Chang PY, Chen JS, Chang SC, Wang MC, Chang NC, Wen YH, Tsai WS, Liu WH, Liu HL, Lu JJ. Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer. Oncotarget 2017;8:72352-62. [PMID: 29069792 DOI: 10.18632/oncotarget.20376] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 259 |
Haumaier F, Sterlacci W, Vieth M. Histological and molecular classification of gastrointestinal polyps. Best Pract Res Clin Gastroenterol 2017;31:369-79. [PMID: 28842046 DOI: 10.1016/j.bpg.2017.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 260 |
Berntsson J, Svensson MC, Leandersson K, Nodin B, Micke P, Larsson AH, Eberhard J, Jirström K. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study. Int J Cancer 2017;141:1654-66. [PMID: 28677162 DOI: 10.1002/ijc.30869] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 261 |
Sun Z, Liu J, Jing H, Dong SX, Wu J. The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review. Oncotarget. 2017;8:89142-89148. [PMID: 29179506 DOI: 10.18632/oncotarget.19408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 262 |
Lock FE, Babaian A, Zhang Y, Gagnier L, Kuah S, Weberling A, Karimi MM, Mager DL. A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancer. PLoS One 2017;12:e0180659. [PMID: 28715472 DOI: 10.1371/journal.pone.0180659] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 263 |
Xiang S, Xiang T, Xiao Q, Li Y, Shao B, Luo T. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer. Int J Oncol 2017;51:801-11. [PMID: 28677721 DOI: 10.3892/ijo.2017.4064] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 264 |
Schirripa M, Cohen SA, Battaglin F, Lenz HJ. Biomarker-driven and molecular targeted therapies for colorectal cancers. Semin Oncol 2018;45:124-32. [PMID: 30262397 DOI: 10.1053/j.seminoncol.2017.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 265 |
Hamzehzadeh L, Yousefi M, Ghaffari SH. Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods. Int J Hematol Oncol Stem Cell Res 2017;11:250-61. [PMID: 28989593] [Reference Citation Analysis]
|
| 266 |
Apidianakis Y. Flies to Humans - Humans to Flies: A Virtuous Circle of Colorectal Cancer Prevention. Arch Clin Gastroenterol 2017. [DOI: 10.17352/2455-2283.000038] [Reference Citation Analysis]
|
| 267 |
He T, Zhang M, Zheng R, Zheng S, Linghu E, Herman JG, Guo M. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer. Epigenomics 2017;9:849-62. [DOI: 10.2217/epi-2017-0019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 268 |
Attiya AA, Almaghraby HQ, Satti MB. An Unusual Variant of Adenocarcinoma of the Left Colon Associated With Microsatellite Instability: A Case Report. Int J Surg Pathol 2017;25:550-4. [PMID: 28537083 DOI: 10.1177/1066896917701576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 269 |
Park PG, Jo SJ, Kim MJ, Kim HJ, Lee JH, Park CK, Kim H, Lee KY, Kim H, Park JH, Dong SM, Lee JM. Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis. Oncotarget 2017;8:80325-35. [PMID: 29113306 DOI: 10.18632/oncotarget.18170] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 270 |
Cheung AH, Iyer DN, Lam CS, Ng L, Wong SKM, Lee HS, Wan T, Man J, Chow AKM, Poon RT, Pang R, Law WL. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis. Int J Mol Sci 2017;18:E1106. [PMID: 28545226 DOI: 10.3390/ijms18061106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 271 |
Ryan E, Sheahan K, Creavin B, Mohan HM, Winter DC. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing. Crit Rev Oncol Hematol. 2017;116:38-57. [PMID: 28693799 DOI: 10.1016/j.critrevonc.2017.05.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 272 |
Xie N, Yao Y, Wan L, Zhu T, Liu L, Yuan J. Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer. Exp Ther Med 2017;14:338-43. [PMID: 28672935 DOI: 10.3892/etm.2017.4464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 273 |
Mahasneh A, Al-Shaheri F, Jamal E. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. Exp Mol Pathol 2017;102:475-83. [PMID: 28506769 DOI: 10.1016/j.yexmp.2017.05.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 274 |
Brijwani N, Jain M, Dhandapani M, Zahed F, Mukhopadhyay P, Biswas M, Khatri D, Radhakrishna VD, Majumder B, Radhakrishnan P, Thiyagarajan S. Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2. Sci Rep 2017;7:1502. [PMID: 28473715 DOI: 10.1038/s41598-017-01566-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 275 |
Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V, Kalogeras KT, Fountzilas G, Grady WM. The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases. Clin Epigenetics 2017;9:46. [PMID: 28469732 DOI: 10.1186/s13148-017-0347-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 276 |
Savio AJ, Mrkonjic M, Lemire M, Gallinger S, Knight JA, Bapat B. The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer. Clin Epigenetics. 2017;9:26. [PMID: 28293327 DOI: 10.1186/s13148-017-0326-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 277 |
Brawley OW. Disparities in Cancer Care. Holland-Frei Cancer Medicine 2017. [DOI: 10.1002/9781119000822.hfcm075] [Reference Citation Analysis]
|
| 278 |
Sefrioui D, Vermeulin T, Blanchard F, Chapusot C, Beaussire L, Armengol-debeir L, Sesboué R, Gangloff A, Hebbar M, Copin M, Houivet E, Schwarz L, Clatot F, Tuech J, Bénichou J, Martin L, Bouvier A, Sabourin J, Sarafan-vasseur N, Frébourg T, Lepage C, Michel P, Di Fiore F. Copy number variations in DCC/ 18q and ERBB2/ 17q are associated with disease-free survival in microsatellite stable colon cancer: Copy number variations in DCC/18Q and ERBB2/17Q in colon cancer. Int J Cancer 2017;140:1653-61. [DOI: 10.1002/ijc.30584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 279 |
Zhong X, Shen H, Mao J, Zhang J, Han W. Epigenetic silencing of protocadherin 10 in colorectal cancer. Oncol Lett. 2017;13:2449-2453. [PMID: 28454418 DOI: 10.3892/ol.2017.5733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 280 |
Ismael NE, El Sheikh SA, Talaat SM, Salem EM. Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study. Open Access Maced J Med Sci 2017;5:9-13. [PMID: 28293308 DOI: 10.3889/oamjms.2017.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 281 |
Carethers JM. Microsatellite Instability Pathway and EMAST in Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13:73-80. [PMID: 28367107 DOI: 10.1007/s11888-017-0352-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 282 |
Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci 2017;18:E197. [PMID: 28106826 DOI: 10.3390/ijms18010197] [Cited by in Crossref: 520] [Cited by in F6Publishing: 563] [Article Influence: 86.7] [Reference Citation Analysis]
|
| 283 |
Thomas J, Shi C. Molecular Testing in Colorectal Cancer. Diagnostic Molecular Pathology 2017. [DOI: 10.1016/b978-0-12-800886-7.00024-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 284 |
Ye M, Huang T, Li J, Zhou C, Yang P, Ni C, Chen S. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines. Medicine (Baltimore) 2017;96:e5956. [PMID: 28121942 DOI: 10.1097/MD.0000000000005956] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 285 |
Zimmermann A. Pathogenic Features of Colorectal Liver Metastasis: Prometastatic and Antimetastatic Genes. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_115] [Reference Citation Analysis]
|
| 286 |
Hartmann D, Friess H. Adenocarcinomas ☆. Reference Module in Life Sciences 2017. [DOI: 10.1016/b978-0-12-809633-8.06013-1] [Reference Citation Analysis]
|
| 287 |
Huang T, Lin C, Zhong LL, Zhao L, Zhang G, Lu A, Wu J, Bian Z. Targeting histone methylation for colorectal cancer. Therap Adv Gastroenterol 2017;10:114-31. [PMID: 28286564 DOI: 10.1177/1756283X16671287] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 288 |
Dénes MI, Borz C, Török Á, Kántor T, Nădășan V, Csibi M, Ábrám Z. The Role of Smoking in the Development of Colorectal Cancer. Acta Medica Marisiensis 2016;62:400-2. [DOI: 10.1515/amma-2016-0046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 289 |
Amaro A, Chiara S, Pfeffer U. Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang. Cancer Metastasis Rev 2016;35:63-74. [PMID: 26947218 DOI: 10.1007/s10555-016-9606-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 290 |
Wu H, Zhang XY, Hu Z, Hou Q, Zhang H, Li Y, Li S, Yue J, Jiang Z, Weissman SM. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing. Oncogene. 2017;36:2857-2867. [PMID: 27941887 DOI: 10.1038/onc.2016.438] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 291 |
Mahathre MM, Rida PC, Aneja R. The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers. J Biomed Res 2016;30:441-51. [PMID: 27924065 DOI: 10.7555/JBR.30.20150109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 292 |
Morris SM, Davison J, Carter KT, O'Leary RM, Trobridge P, Knoblaugh SE, Myeroff LL, Markowitz SD, Brett BT, Scheetz TE, Dupuy AJ, Starr TK, Grady WM. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms. Int J Cancer. 2017;140:853-863. [PMID: 27790711 DOI: 10.1002/ijc.30491] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 293 |
Behrouz Sharif S, Hashemzadeh S, Mousavi Ardehaie R, Eftekharsadat A, Ghojazadeh M, Mehrtash AH, Estiar MA, Teimoori-Toolabi L, Sakhinia E. Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker. Oncol Lett. 2016;12:5335-5343. [PMID: 28105243 DOI: 10.3892/ol.2016.5327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 294 |
Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: A review. Cancer Treat Rev. 2016;51:19-26. [PMID: 27838401 DOI: 10.1016/j.ctrv.2016.10.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 154] [Article Influence: 19.9] [Reference Citation Analysis]
|
| 295 |
Yang F, Gong Q, Shi W, Zou Y, Shi J, Wei F, Li Q, Chen J, Li WD. Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation. Tumour Biol 2016;37:12609-18. [PMID: 27405564 DOI: 10.1007/s13277-016-5130-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 296 |
Nando Y, Watari J, Ito C, Hara K, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Tomita T, Ohda Y, Oshima T, Fukui H, Matsubara N, Tomita N, Hirota S, Miwa H. Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum. Hum Pathol 2017;60:37-45. [PMID: 27746269 DOI: 10.1016/j.humpath.2016.09.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 297 |
Li W, Li C, Zheng H, Chen G, Hua B. Therapeutic targets of Traditional Chinese Medicine for colorectal cancer. J Tradit Chin Med. 2016;36:243-249. [PMID: 27400481 DOI: 10.1016/s0254-6272(16)30034-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 298 |
Semaan A, van Ellen A, Meller S, Bergheim D, Branchi V, Lingohr P, Goltz D, Kalff JC, Kristiansen G, Matthaei H, Pantelis D, Dietrich D. SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas. Clin Epigenetics. 2016;8:100. [PMID: 27660666 DOI: 10.1186/s13148-016-0267-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 299 |
Shen X, Yue M, Meng F, Zhu J, Zhu X, Jiang Y. Microarray analysis of differentially-expressed genes and linker genes associated with the molecular mechanism of colorectal cancer. Oncol Lett 2016;12:3250-8. [PMID: 27899990 DOI: 10.3892/ol.2016.5122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 300 |
Lee K, Ferguson LR. MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer. World J Gastroenterol 2016; 22(33): 7389-7401 [PMID: 27672263 DOI: 10.3748/wjg.v22.i33.7389] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 301 |
Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang K, Go MY, Ng SC, Chan FK, Sung JJ, Yu J. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis. Gut 2016;65:1482-93. [PMID: 26071132 DOI: 10.1136/gutjnl-2014-308614] [Cited by in Crossref: 90] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 302 |
Jayathilake AG, Senior PV, Su XQ. Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells. BMC Complement Altern Med 2016;16:328. [PMID: 27576529 DOI: 10.1186/s12906-016-1311-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 303 |
Carethers JM. Neoplasia. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch31] [Reference Citation Analysis]
|
| 304 |
Luo X, Huang R, Sun H, Liu Y, Bi H, Li J, Yu H, Sun J, Lin S, Cui B, Zhao Y. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer. Sci Rep. 2016;6:29922. [PMID: 27453436 DOI: 10.1038/srep29922] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 305 |
Cui J, Cai Y, Hu Y, Huang Z, Luo Y, Kaz AM, Yang Z, Chen D, Fan X, Grady WM, Wang J. Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation. Tumour Biol 2016;37:12477-83. [PMID: 27333992 DOI: 10.1007/s13277-016-5103-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 306 |
Jones LR, Greene J, Chen KM, Divine G, Chitale D, Shah V, Datta I, Worsham MJ. Biological significance of genome-wide DNA methylation profiles in keloids: DNA Methylation Profiles in Keloids. The Laryngoscope 2017;127:70-8. [DOI: 10.1002/lary.26063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 307 |
Carethers JM. GRG Profiles: John M. Carethers. Dig Dis Sci 2016;61:1429-35. [PMID: 26846119 DOI: 10.1007/s10620-016-4058-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 308 |
Ricciardiello L, Ahnen DJ, Lynch PM. Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol 2016;13:352-61. [PMID: 27095653 DOI: 10.1038/nrgastro.2016.56] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 309 |
Kim JS, Kim YG, Park EJ, Kim B, Lee HK, Hong JT, Kim Y, Han SB. Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells. Immune Netw 2016;16:99-108. [PMID: 27162526 DOI: 10.4110/in.2016.16.2.99] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 310 |
Watson MM, Lea D, Rewcastle E, Hagland HR, Søreide K. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different? Cancer Med 2016;5:1580-7. [PMID: 27061136 DOI: 10.1002/cam4.709] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 311 |
Karadima ML, Saetta AA, Chatziandreou I, Lazaris AC, Patsouris E, Tsavaris N. The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer. Pathol Oncol Res 2016;22:707-14. [DOI: 10.1007/s12253-016-0056-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 312 |
Waldmann E, Ferlitsch M, Binder N, Sellner F, Karner J, Heinisch B, Klimpfinger M, Trauner M. Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer. Digestion 2015;91:286-93. [PMID: 25924923 DOI: 10.1159/000381284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 313 |
Cougnoux A, Delmas J, Gibold L, Faïs T, Romagnoli C, Robin F, Cuevas-Ramos G, Oswald E, Darfeuille-Michaud A, Prati F, Dalmasso G, Bonnet R. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. Gut 2016;65:278-85. [PMID: 25588406 DOI: 10.1136/gutjnl-2014-307241] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 314 |
Zhai RL, Xu F, Zhang P, Zhang WL, Wang H, Wang JL, Cai KL, Long YP, Lu XM, Tao KX, Wang GB. The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2016;95:e2129. [PMID: 26844449 DOI: 10.1097/MD.0000000000002129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 315 |
Subramaniam R, Mizoguchi A, Mizoguchi E. Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer. Cancer Res Front. 2016;2:1-21. [PMID: 27110580 DOI: 10.17980/2016.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 316 |
Tripathi S, Belkacemi L, Cheung MS, Bose RN. Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers. Cancer Inform 2016;15:1-13. [PMID: 26819545 DOI: 10.4137/CIN.S34506] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 317 |
Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer 2016;35:4. [PMID: 26738600 DOI: 10.1186/s40880-015-0066-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 318 |
Zimmermann A. Pathogenic Features of Colorectal Liver Metastasis: Prometastatic and Antimetastatic Genes. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_115-1] [Reference Citation Analysis]
|
| 319 |
Bhaw-luximon A, Goonoo N, Jhurry D. Nanotherapeutics promises for colorectal cancer and pancreatic ductal adenocarcinoma. Nanobiomaterials in Cancer Therapy 2016. [DOI: 10.1016/b978-0-323-42863-7.00006-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 320 |
Cisyk AL, Penner-Goeke S, Lichtensztejn Z, Nugent Z, Wightman RH, Singh H, McManus KJ. Characterizing the prevalence of chromosome instability in interval colorectal cancer. Neoplasia 2015;17:306-16. [PMID: 25810015 DOI: 10.1016/j.neo.2015.02.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 321 |
Xue M, Lai SC, Xu ZP, Wang LJ. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review. J Dig Dis 2015;16:699-712. [PMID: 26565661 DOI: 10.1111/1751-2980.12299] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 322 |
Chen H, Xu Z. Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer. Dis Markers 2015;2015:345080. [PMID: 26693202 DOI: 10.1155/2015/345080] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 323 |
Sakai E, Fukuyo M, Ohata K, Matsusaka K, Doi N, Mano Y, Takane K, Abe H, Yagi K, Matsuhashi N. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway. Int J Cancer. 2016;138:1634-1644. [PMID: 26510091 DOI: 10.1002/ijc.29903] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 324 |
Cohen SA, Wu C, Yu M, Gourgioti G, Wirtz R, Raptou G, Gkakou C, Kotoula V, Pentheroudakis G, Papaxoinis G, Karavasilis V, Pectasides D, Kalogeras KT, Fountzilas G, Grady WM. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Clin Colorectal Cancer 2016;15:164-9. [PMID: 26702772 DOI: 10.1016/j.clcc.2015.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 325 |
Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers 2015;1:15065. [PMID: 27189416 DOI: 10.1038/nrdp.2015.65] [Cited by in Crossref: 795] [Cited by in F6Publishing: 845] [Article Influence: 99.4] [Reference Citation Analysis]
|
| 326 |
Bauer J, Ozden O, Akagi N, Carroll T, Principe DR, Staudacher JJ, Spehlmann ME, Eckmann L, Grippo PJ, Jung B. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer 2015;14:182. [PMID: 26497569 DOI: 10.1186/s12943-015-0456-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 327 |
Chang SC, Lin PC, Lin JK, Lin CH, Yang SH, Liang WY, Chen WS, Jiang JK. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis. Ann Surg Oncol 2016;23:849-55. [PMID: 26471487 DOI: 10.1245/s10434-015-4899-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 328 |
Shiovitz S, Grady WM. Molecular markers predictive of chemotherapy response in colorectal cancer. Curr Gastroenterol Rep 2015;17:431. [PMID: 25663616 DOI: 10.1007/s11894-015-0431-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 329 |
Carethers JM, Jung BH. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. Gastroenterology 2015;149:1177-1190.e3. [PMID: 26216840 DOI: 10.1053/j.gastro.2015.06.047] [Cited by in Crossref: 254] [Cited by in F6Publishing: 281] [Article Influence: 31.8] [Reference Citation Analysis]
|
| 330 |
Ezuka A, Sakai E, Kawana K, Nagase H, Kakuta Y, Uchiyama S, Ohkubo H, Higurashi T, Nonaka T, Endo H, Takahashi H, Nakajima A. Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans. Oncol Lett. 2015;10:3689-3695. [PMID: 26788192 DOI: 10.3892/ol.2015.3763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 331 |
Shivakumar BM, Rotti H, Vasudevan TG, Balakrishnan A, Chakrabarty S, Bhat G, Rao L, Pai CG, Satyamoorthy K. Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis. World J Gastroenterol. 2015;21:616-622. [PMID: 25605985 DOI: 10.3748/wjg.v21.i2.599] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 332 |
Dickinson BT, Kisiel J, Ahlquist DA, Grady WM. Molecular markers for colorectal cancer screening. Gut 2015;64:1485-94. [PMID: 25994221 DOI: 10.1136/gutjnl-2014-308075] [Cited by in Crossref: 72] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 333 |
Carethers JM, Stoffel EM. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World J Gastroenterol 2015; 21(31): 9253-9261 [PMID: 26309352 DOI: 10.3748/wjg.v21.i31.9253] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 129] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 334 |
Kit OI, Vodolazhsky DI. Molecular biology of colorectal cancer in clinical practice. Mol Biol 2015;49:471-9. [DOI: 10.1134/s0026893315040081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 335 |
Wang H, Liang L, Fang JY, Xu J. Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene 2016;35:2011-9. [PMID: 26257062 DOI: 10.1038/onc.2015.304] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 336 |
Puerta-García E, Cañadas-Garre M, Calleja-Hernández MÁ. Molecular biomarkers in colorectal carcinoma. Pharmacogenomics 2015;16:1189-222. [PMID: 26237292 DOI: 10.2217/PGS.15.63] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 337 |
Mori K, Toiyama Y, Saigusa S, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Dig Dis Sci 2015;60:2477-87. [PMID: 25840921 DOI: 10.1007/s10620-015-3648-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 338 |
Sinicrope FA, Mahoney MR, Yoon HH, Smyrk TC, Thibodeau SN, Goldberg RM, Nelson GD, Sargent DJ, Alberts SR. Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance). Clin Cancer Res. 2015;21:5294-5304. [PMID: 26187617 DOI: 10.1158/1078-0432.ccr-15-0527] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 339 |
Zhong R, Chen X, Chen X, Zhu B, Lou J, Li J, Shen N, Yang Y, Gong Y, Zhu Y, Yuan J, Xia X, Miao X. MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer. Sci Rep 2015;5:12202. [PMID: 26183163 DOI: 10.1038/srep12202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 340 |
Lv J, Fan N, Wang Y, Wang X, Gao C. Identification of differentially expressed proteins of normal and cancerous human colorectal tissues by liquid chromatograph-mass spectrometer based on iTRAQ approach. Cancer Invest 2015;33:420-8. [PMID: 26180943 DOI: 10.3109/07357907.2015.1055757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 341 |
Sekal M, Ameurtesse H, Chbani L, Ouldim K, Bennis S, Abkari M, Boulouz A, Benajah DA, Benjelloun B, Ousadden A, Ait Taleb K, Ait Laalim S, Toghrai I, Mazaz K, Arifi S, Mellas N, El Rhazi K, Harmouch T, Ibrahimi SA, Amarti Riffi A. Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration. Diagn Pathol 2015;10:77. [PMID: 26104511 DOI: 10.1186/s13000-015-0326-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 342 |
Li W, Zhi W, Zou S, Qiu T, Ling Y, Shan L, Shi S, Ying J. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations. PLoS One 2015;10:e0128202. [PMID: 26042813 DOI: 10.1371/journal.pone.0128202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 343 |
Lynch HT, Drescher K, Knezetic J, Lanspa S. Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review. Curr Treat Options Oncol. 2014;15:429-442. [PMID: 24827900 DOI: 10.1007/s11864-014-0293-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 344 |
Hamaya Y, Guarinos C, Tseng-Rogenski SS, Iwaizumi M, Das R, Jover R, Castells A, Llor X, Andreu M, Carethers JM. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer. PLoS One. 2015;10:e0127591. [PMID: 25996601 DOI: 10.1371/journal.pone.0127591] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 345 |
Tsai M, Chen W, Yu S, Chen C, Jao T, Huang C, Tzeng S, Yen S, Yang Y. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis. Ann Surg Oncol 2015;22:1481-9. [DOI: 10.1245/s10434-015-4593-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 346 |
Venderbosch S, van Lent-van Vliet S, de Haan AF, Ligtenberg MJ, Goossens M, Punt CJ, Koopman M, Nagtegaal ID. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer. PLoS One 2015;10:e0124538. [PMID: 25884216 DOI: 10.1371/journal.pone.0124538] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 347 |
Leichsenring J, Koppelle A, Reinacher-Schick A. Colorectal Cancer: Personalized Therapy. Gastrointest Tumors 2014;1:209-20. [PMID: 26676107 DOI: 10.1159/000380790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 348 |
Zhang L, Fan XM. The pathological role of microRNAs and inflammation in colon carcinogenesis. Clin Res Hepatol Gastroenterol 2015;39:174-9. [PMID: 25154001 DOI: 10.1016/j.clinre.2014.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 349 |
Tahir AA, Sani NF, Murad NA, Makpol S, Ngah WZ, Yusof YA. Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells. Nutr J. 2015;14:31. [PMID: 25889965 DOI: 10.1186/s12937-015-0015-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 350 |
Xu Z, Chen H, Liu D, Huo J. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study. Medicine (Baltimore) 2015;94:e663. [PMID: 25837757 DOI: 10.1097/MD.0000000000000663] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 351 |
Sutton PA, Jones RP, Evans JP, Kitteringham N, Goldring C, Palmer DH, Vimalachandran D, Malik HZ. Predicting response to treatment for colorectal cancer: a review of relevant mechanisms and potential biomarkers. Colorectal Cancer 2015;4:85-95. [DOI: 10.2217/crc.15.11] [Reference Citation Analysis]
|
| 352 |
Carethers JM, Koi M, Tseng-Rogenski SS. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression. Genes (Basel). 2015;6:185-205. [PMID: 25836926 DOI: 10.3390/genes6020185] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 353 |
Sun D, Wang C, Long S, Ma Y, Guo Y, Huang Z, Chen X, Zhang C, Chen J, Zhang J. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer. Br J Cancer 2015;112:1491-500. [PMID: 25867276 DOI: 10.1038/bjc.2015.107] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 354 |
Kuan JC, Wu CC, Sun CA, Chu CM, Lin FG, Hsu CH, Kan PC, Lin SC, Yang T, Chou YC. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study. PLoS One. 2015;10:e0123396. [PMID: 25815725 DOI: 10.1371/journal.pone.0123396] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 355 |
Lee SK, Moon JW, Lee YW, Lee JO, Kim SJ, Kim N, Kim J, Kim HS, Park S. The effect of high glucose levels on the hypermethylation of protein phosphatase 1 regulatory subunit 3C (PPP1R3C) gene in colorectal cancer. J Genet 2015;94:75-85. [DOI: 10.1007/s12041-015-0492-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 356 |
Hajrezaie M, Paydar M, Looi CY, Moghadamtousi SZ, Hassandarvish P, Salga MS, Karimian H, Shams K, Zahedifard M, Majid NA, Ali HM, Abdulla MA. Apoptotic effect of novel Schiff based CdCl₂(C₁₄H₂₁N₃O₂) complex is mediated via activation of the mitochondrial pathway in colon cancer cells. Sci Rep 2015;5:9097. [PMID: 25764970 DOI: 10.1038/srep09097] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 357 |
Sønderstrup IM, Nygård SB, Poulsen TS, Linnemann D, Stenvang J, Nielsen HJ, Bartek J, Brünner N, Nørgaard P, Riis L. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers. Mol Oncol 2015;9:1207-17. [PMID: 25777966 DOI: 10.1016/j.molonc.2015.02.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 358 |
Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2015;308:G351-63. [PMID: 25540232 DOI: 10.1152/ajpgi.00360.2012] [Cited by in Crossref: 132] [Cited by in F6Publishing: 141] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 359 |
Carethers JM. Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 2015;60:711-21. [PMID: 25540085 DOI: 10.1007/s10620-014-3443-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 360 |
Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci 2015;60:762-72. [PMID: 25492499 DOI: 10.1007/s10620-014-3444-4] [Cited by in Crossref: 105] [Cited by in F6Publishing: 109] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 361 |
Tseng-Rogenski SS, Hamaya Y, Choi DY, Carethers JM. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells. Gastroenterology 2015;148:579-89. [PMID: 25461668 DOI: 10.1053/j.gastro.2014.11.027] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 362 |
Knickelbein K, Zhang L. Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer. Genes Dis 2015;2:4-12. [PMID: 25815366 DOI: 10.1016/j.gendis.2014.10.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 363 |
Li WH, Zhang H, Guo Q, Wu XD, Xu ZS, Dang CX, Xia P, Song YC. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Dis Markers. 2015;2015:657570. [PMID: 25802477 DOI: 10.1155/2015/657570] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 364 |
Scott A, Wang ZJ. Colon cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.025] [Reference Citation Analysis]
|
| 365 |
Current state of the evolving MMMN cancer progression models of cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.022] [Reference Citation Analysis]
|
| 366 |
Guo Y, Shu L, Zhang C, Su ZY, Kong AN. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochem Pharmacol 2015;94:69-78. [PMID: 25640947 DOI: 10.1016/j.bcp.2015.01.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 367 |
Shivakumar BM, Rotti H, Vasudevan TG, Balakrishnan A, Chakrabarty S, Bhat G, Rao L, Pai CG, Satyamoorthy K. Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis. World J Gastroenterol 2015; 21(2): 616-622 [PMID: 25605985 DOI: 10.3748/wjg.v21.i2.616] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 368 |
Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology 2015;148:88-99. [PMID: 25305506 DOI: 10.1053/j.gastro.2014.09.041] [Cited by in Crossref: 227] [Cited by in F6Publishing: 239] [Article Influence: 28.4] [Reference Citation Analysis]
|
| 369 |
Mendez-gonzalez J, Sandoval J. Epigenomic Biomarkers for the Advance of Personalized Medicine. Translational Bioinformatics 2015. [DOI: 10.1007/978-94-017-9927-0_9] [Reference Citation Analysis]
|
| 370 |
Seneviratne D, Ma J, Tan X, Kwon YK, Muhammad E, Melhem M, DeFrances MC, Zarnegar R. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis. Gastroenterology 2015;148:181-191.e17. [PMID: 25244939 DOI: 10.1053/j.gastro.2014.09.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 371 |
Raskov H, Pommergaard HC, Burcharth J, Rosenberg J. Colorectal carcinogenesis-update and perspectives. World J Gastroenterol 2014; 20(48): 18151-18164 [PMID: 25561783 DOI: 10.3748/wjg.v20.i48.18151] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 118] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 372 |
Renaud F, Vincent A, Mariette C, Crépin M, Stechly L, Truant S, Copin MC, Porchet N, Leteurtre E, Van Seuningen I, Buisine MP. MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer. Int J Cancer 2015;136:2811-21. [PMID: 25403854 DOI: 10.1002/ijc.29342] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 373 |
Han F, Liu W, Jiang X, Shi X, Yin L, Ao L, Cui Z, Li Y, Huang C, Cao J, Liu J. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer. Oncogene 2015;34:4391-402. [PMID: 25435374 DOI: 10.1038/onc.2014.370] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 374 |
Read ML, Seed RI, Modasia B, Kwan PP, Sharma N, Smith VE, Watkins RJ, Bansal S, Gagliano T, Stratford AL, Ismail T, Wakelam MJ, Kim DS, Ward ST, Boelaert K, Franklyn JA, Turnell AS, McCabe CJ. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer. Mol Carcinog 2016;55:15-26. [PMID: 25408419 DOI: 10.1002/mc.22254] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 375 |
Heng HH, Bremer SW, Stevens JB, Horne SD, Liu G, Abdallah BY, Ye KJ, Ye CJ. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution. Cancer Metastasis Rev 2013;32:325-40. [PMID: 23605440 DOI: 10.1007/s10555-013-9427-7] [Cited by in Crossref: 118] [Cited by in F6Publishing: 133] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 376 |
Sanchez-Tapia C, Wan FY. Fastest time to cancer by loss of tumor suppressor genes. Bull Math Biol 2014;76:2737-84. [PMID: 25338553 DOI: 10.1007/s11538-014-0027-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 377 |
Cisyk AL, Singh H, McManus KJ. Establishing a biological profile for interval colorectal cancers. Dig Dis Sci 2014;59:2390-402. [PMID: 24839919 DOI: 10.1007/s10620-014-3210-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 378 |
Shiovitz S, Bertagnolli MM, Renfro LA, Nam E, Foster NR, Dzieciatkowski S, Luo Y, Lao VV, Monnat RJ Jr, Emond MJ, Maizels N, Niedzwiecki D, Goldberg RM, Saltz LB, Venook A, Warren RS, Grady WM; Alliance for Clinical Trials in Oncology. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Gastroenterology 2014;147:637-45. [PMID: 24859205 DOI: 10.1053/j.gastro.2014.05.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 102] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 379 |
Proctor DM, Suh M, Campleman SL, Thompson CM. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicology 2014;325:160-79. [PMID: 25174529 DOI: 10.1016/j.tox.2014.08.009] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 380 |
Li X, Hu F, Wang Y, Yao X, Zhang Z, Wang F, Sun G, Cui BB, Dong X, Zhao Y. CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China. Biomed Res Int. 2014;2014:236361. [PMID: 25243122 DOI: 10.1155/2014/236361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 381 |
Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology 2014;147:418-29.e8. [PMID: 24793120 DOI: 10.1053/j.gastro.2014.04.039] [Cited by in Crossref: 140] [Cited by in F6Publishing: 142] [Article Influence: 15.6] [Reference Citation Analysis]
|
| 382 |
Hosseinpour B, Bakhtiarizadeh MR, Mirabbassi SM, Ebrahimie E. Comparison of hematopoietic cancer stem cells with normal stem cells leads to discovery of novel differentially expressed SSRs. Gene 2014;550:10-7. [PMID: 25084127 DOI: 10.1016/j.gene.2014.07.069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 383 |
Bathe OF, Farshidfar F. From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer. Genes (Basel) 2014;5:536-60. [PMID: 25055199 DOI: 10.3390/genes5030536] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 384 |
Ayiomamitis GD, Notas G, Zaravinos A, Zizi-Sermpetzoglou A, Georgiadou M, Sfakianaki O, Kouroumallis E. Differences in telomerase activity between colon and rectal cancer. Can J Surg 2014;57:199-208. [PMID: 24869613 DOI: 10.1503/cjs.031312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 385 |
de Jong PR, Mo JH, Harris AR, Lee J, Raz E. STAT3: An Anti-Invasive Factor in Colorectal Cancer? Cancers (Basel). 2014;6:1394-1407. [PMID: 24995503 DOI: 10.3390/cancers6031394] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 386 |
Huth L, Jäkel J, Dahl E. Molecular Diagnostic Applications in Colorectal Cancer. Microarrays (Basel) 2014;3:168-79. [PMID: 27600342 DOI: 10.3390/microarrays3030168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 387 |
Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, Smith EJ, Lee M, Janke R, Ngo T, Tejada R, Ji M, Kinseth M, Cabrera BL, Miyai K, Keku TO, Martin CF, Galanko JA, Sandler RS, McGuire KL. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One 2014;9:e100461. [PMID: 24956473 DOI: 10.1371/journal.pone.0100461] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 388 |
Shanmugam V, Ramanathan RK, Lavender NA, Sinari S, Chadha M, Liang WS, Kurdoglu A, Izatt T, Christoforides A, Benson H, Phillips L, Baker A, Murray C, Hostetter G, Von Hoff DD, Craig DW, Carpten JD. Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer. BMC Med Genomics 2014;7:36. [PMID: 24943349 DOI: 10.1186/1755-8794-7-36] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 389 |
Wang DQ, Wang K, Yan DW, Liu J, Wang B, Li MX, Wang XW, Liu J, Peng ZH, Li GX. Ciz1 is a novel predictor of survival in human colon cancer. Exp Biol Med (Maywood). 2014;239:862-870. [PMID: 24928862 DOI: 10.1177/1535370213520113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 390 |
Fiorina L, Ricotti M, Vanoli A, Luinetti O, Dallera E, Riboni R, Paolucci S, Brugnatelli S, Paulli M, Pedrazzoli P, Baldanti F, Perfetti V. Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. Infect Agent Cancer. 2014;9:18. [PMID: 24936208 DOI: 10.1186/1750-9378-9-18] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 391 |
Agle SC, Philips P, Martin RCG. Environmental Exposures, Tumor Heterogeneity, and Colorectal Cancer Outcomes. Curr Colorectal Cancer Rep 2014;10:189-194. [DOI: 10.1007/s11888-014-0221-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 392 |
Zhang H, Zhu YQ, Wu YQ, Zhang P, Qi J. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World J Gastroenterol 2014; 20(20): 6329-6335 [PMID: 24876755 DOI: 10.3748/wjg.v20.i20.6329] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 393 |
Etienne-Grimaldi MC, Mahamat A, Chazal M, Laurent-Puig P, Olschwang S, Gaub MP, Formento JL, Formento P, Sudaka A, Boige V, Abderrahim-Ferkoune A, Benchimol D, André T, Houry S, Faucheron JL, Letoublon C, Gilly FN, Delpero JR, Lasser P, Pradere B, Pezet D, Penault-Llorca F, Milano G. Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study. Br J Cancer 2014;110:2728-37. [PMID: 24800948 DOI: 10.1038/bjc.2014.213] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 394 |
Kastrinos F, Stoffel EM. History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol 2014;12:715-27; quiz e41-3. [PMID: 23891921 DOI: 10.1016/j.cgh.2013.06.031] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 395 |
Hofmanová J, Straková N, Vaculová AH, Tylichová Z, Safaříková B, Skender B, Kozubík A. Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer. Mediators Inflamm 2014;2014:848632. [PMID: 24876678 DOI: 10.1155/2014/848632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 396 |
Yasunaga M, Matsumura Y. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. Sci Rep. 2014;4:4852. [PMID: 24781822 DOI: 10.1038/srep04852] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 397 |
Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis. Int J Cancer 2014;135:2593-603. [PMID: 24740680 DOI: 10.1002/ijc.28899] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 398 |
Narasimhan K, Gauthaman K, Pushparaj PN, Meenakumari G, Chaudhary AGA, Abuzenadah A, Gari MA, Al Qahtani M, Manikandan J. Identification of Unique miRNA Biomarkers in Colorectal Adenoma and Carcinoma Using Microarray: Evaluation of Their Putative Role in Disease Progression. ISRN Cell Biology 2014;2014:1-10. [DOI: 10.1155/2014/526075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 399 |
Kim JH, Kang GH. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. World J Gastroenterol 2014; 20(15): 4230-4243 [PMID: 24764661 DOI: 10.3748/wjg.v20.i15.4230] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 400 |
Irrazábal T, Belcheva A, Girardin S, Martin A, Philpott D. The Multifaceted Role of the Intestinal Microbiota in Colon Cancer. Molecular Cell 2014;54:309-20. [DOI: 10.1016/j.molcel.2014.03.039] [Cited by in Crossref: 218] [Cited by in F6Publishing: 187] [Article Influence: 24.2] [Reference Citation Analysis]
|
| 401 |
Read ML, Seed RI, Fong JC, Modasia B, Ryan GA, Watkins RJ, Gagliano T, Smith VE, Stratford AL, Kwan PK, Sharma N, Dixon OM, Watkinson JC, Boelaert K, Franklyn JA, Turnell AS, McCabe CJ. The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells. Endocrinology 2014;155:1222-34. [PMID: 24506068 DOI: 10.1210/en.2013-1646] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 402 |
Piazzi G, D’Argenio G, Prossomariti A, Lembo V, Mazzone G, Candela M, Biagi E, Brigidi P, Vitaglione P, Fogliano V. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer. 2014;135:2004-2013. [PMID: 24676631 DOI: 10.1002/ijc.28853] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 403 |
Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol. 2014;35:6195-6206. [PMID: 25051912 DOI: 10.1007/s13277-014-1845-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 404 |
Maffei F, Zolezzi Moraga JM, Angelini S, Zenesini C, Musti M, Festi D, Cantelli-forti G, Hrelia P. Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk. Mutagenesis 2014;29:221-5. [DOI: 10.1093/mutage/geu007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 405 |
Kim NK. Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer? Ann Coloproctol 2014;30:5-6. [PMID: 24639962 DOI: 10.3393/ac.2014.30.1.5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 406 |
Chai XK, Ju HY, Bai WY. Relationship between methylation of tumor suppressor genes and colorectal cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(8): 1087-1092 [DOI: 10.11569/wcjd.v22.i8.1087] [Reference Citation Analysis]
|
| 407 |
Strambu V, Garofil D, Pop F, Radu P, Bratucu M, Popa F. Translating clinical research of Molecular Biology into a personalized, multidisciplinary approach of colorectal cancer patients. J Med Life 2014;7:17-26. [PMID: 24653752] [Reference Citation Analysis]
|
| 408 |
Sakai E, Ohata K, Chiba H, Matsuhashi N, Doi N, Fukushima J, Endo H, Takahashi H, Tsuji S, Yagi K, Matsusaka K, Aburatani H, Nakajima A, Kaneda A. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors. Int J Cancer 2014;135:1586-95. [PMID: 24590867 DOI: 10.1002/ijc.28814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 409 |
Wang K, Huang C, Nice EC. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers. Expert Rev Proteomics. 2014;11:179-205. [PMID: 24611605 DOI: 10.1586/14789450.2014.894466] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 410 |
Li J, Jin H, Wang X. Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol. 2014;2014:464015. [PMID: 24729878 DOI: 10.1155/2014/464015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 411 |
Carethers JM. Differentiating Lynch-like from Lynch syndrome. Gastroenterology 2014;146:602-4. [PMID: 24468183 DOI: 10.1053/j.gastro.2014.01.041] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 412 |
Carethers JM. DNA testing and molecular screening for colon cancer. Clin Gastroenterol Hepatol 2014;12:377-81. [PMID: 24355100 DOI: 10.1016/j.cgh.2013.12.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 413 |
Haghighi MM, Aghagolzadeh P, Zadeh SM, Molaei M, Zali MR, Radpour R. Telomere shortening: a biological marker of sporadic colorectal cancer with normal expression of p53 and mismatch repair proteins. Genet Test Mol Biomarkers. 2014;18:236-244. [PMID: 24495131 DOI: 10.1089/gtmb.2013.0436] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 414 |
Deb S, Fox SB. Molecular profiling in colorectal cancer: current state of play and future directions. Colorectal Cancer 2014;3:41-56. [DOI: 10.2217/crc.13.82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 415 |
Luo Y, Wang L, Wang J. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges. Proteomics Clin Appl 2013;7:30-41. [PMID: 23255431 DOI: 10.1002/prca.201200071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 416 |
Sanz-garcía E, Elez E, Macarulla T, Dienstmann R, Salazar R, Tabernero J. Prognosis and Therapeutic Implications for Emerging Colorectal Cancer Subtypes. Curr Colorectal Cancer Rep 2014;10:55-61. [DOI: 10.1007/s11888-013-0205-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 417 |
de Groen FL, Krijgsman O, Tijssen M, Vriend LE, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression: 13q Gain in CRC Progression. Genes Chromosomes Cancer 2014;53:339-48. [DOI: 10.1002/gcc.22144] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 418 |
Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 2014; 20(4): 943-956 [PMID: 24574767 DOI: 10.3748/wjg.v20.i4.943] [Cited by in CrossRef: 167] [Cited by in F6Publishing: 174] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 419 |
Sakai E, Nakajima A, Kaneda A. Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol 2014; 20(4): 978-987 [PMID: 24574770 DOI: 10.3748/wjg.v20.i4.978] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 420 |
Luo Y, Yu M, Grady WM. Field cancerization in the colon: a role for aberrant DNA methylation? Gastroenterol Rep (Oxf). 2014;2:16-20. [PMID: 24760232 DOI: 10.1093/gastro/got039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 421 |
Moon JW, Lee SK, Lee JO, Kim N, Lee YW, Kim SJ, Kang HJ, Kim J, Kim HS, Park SH. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer. J Exp Clin Cancer Res 2014;33:4. [PMID: 24393480 DOI: 10.1186/1756-9966-33-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 422 |
Migheli F, Migliore L. Epigenetic Perturbations in the Context of the Multi-hit Hypothesis of Carcinogenesis. Molecular mechanisms and physiology of disease 2014. [DOI: 10.1007/978-1-4939-0706-9_14] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 423 |
Azzoni C, Bottarelli L, Cecchini S, Ziccarelli A, Campanini N, Bordi C, Sarli L, Silini EM. Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associations with clinicopathological and molecular features. Pathol Res Pract 2014;210:111-7. [PMID: 24332575 DOI: 10.1016/j.prp.2013.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 424 |
Park JJ, Lee M. Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver 2013;7:629-41. [PMID: 24312702 DOI: 10.5009/gnl.2013.7.6.629] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 425 |
Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, Khan MA, Bowman ED, Mueller A, Schad A, Shimomura M. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer. 2014;134:1926-1934. [PMID: 24122631 DOI: 10.1002/ijc.28522] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 426 |
Yang H, Xia BQ, Jiang B, Wang G, Yang YP, Chen H, Li BS, Xu AG, Huang YB, Wang XY. Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis. Can J Gastroenterol 2013;27:467-75. [PMID: 23936877 DOI: 10.1155/2013/258030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 427 |
Petit C, Oswald E, Nougayrede J. Rôle des génotoxines produites par des bactéries du microbiote dans le cancer colorectal. Revue Francophone des Laboratoires 2013;2013:77-82. [DOI: 10.1016/s1773-035x(13)72226-3] [Reference Citation Analysis]
|
| 428 |
Grady WM, Pritchard CC. Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol 2014;42:124-39. [PMID: 24178577 DOI: 10.1177/0192623313505155] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 429 |
Stadthagen G, Tehler D, Høyland-Kroghsbo NM, Wen J, Krogh A, Jensen KT, Santoni-Rugiu E, Engelholm LH, Lund AH. Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet 2013;9:e1003913. [PMID: 24204315 DOI: 10.1371/journal.pgen.1003913] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 430 |
Silva TD, Vidigal VM, Felipe AV, DE Lima JM, Neto RA, Saad SS, Forones NM. DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol Lett. 2013;6:1687-1692. [PMID: 24260063 DOI: 10.3892/ol.2013.1606] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 431 |
Sohn S, Cho K, Bae H. Screening for herbal medicines that affect ZIC1 gene methylation in colorectal cancer. Mol Cell Toxicol 2013;9:211-8. [DOI: 10.1007/s13273-013-0027-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 432 |
Moorcraft SY, Smyth EC, Cunningham D. The role of personalized medicine in metastatic colorectal cancer: an evolving landscape. Therap Adv Gastroenterol 2013;6:381-95. [PMID: 24003339 DOI: 10.1177/1756283X13491797] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 433 |
Zauber P, Huang J, Sabbath-solitare M, Marotta S. Similarities of Molecular Genetic Changes in Synchronous and Metachronous Colorectal Cancers Are Limited and Related to the Cancers’ Proximities to Each Other. The Journal of Molecular Diagnostics 2013;15:652-60. [DOI: 10.1016/j.jmoldx.2013.03.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 434 |
Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, Hixon JG, Harris MA. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol 2014;34:525-36. [PMID: 23943231 DOI: 10.1002/jat.2907] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 435 |
Pitule P, Čedíková M, Třeška V, Králíčková M, Liška V. Assessing colorectal cancer heterogeneity: one step closer to tailored medicine. J Appl Biomed 2013;11:115-29. [DOI: 10.2478/v10136-012-0035-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 436 |
Thompson CM, Proctor DM, Suh M, Haws LC, Kirman CR, Harris MA. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol 2013;43:244-74. [PMID: 23445218 DOI: 10.3109/10408444.2013.768596] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 437 |
Luo Y, Kaz AM, Kanngurn S, Welsch P, Morris SM, Wang J, Lutterbaugh JD, Markowitz SD, Grady WM. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet 2013;9:e1003552. [PMID: 23874207 DOI: 10.1371/journal.pgen.1003552] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 438 |
Voorham QJ, Rondagh EJ, Knol DL, van Engeland M, Carvalho B, Meijer GA, Sanduleanu S. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis. Am J Gastroenterol 2013;108:1042-56. [PMID: 23649184 DOI: 10.1038/ajg.2013.126] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 439 |
Haeno H, Maruvka YE, Iwasa Y, Michor F. Stochastic Tunneling of Two Mutations in a Population of Cancer Cells. PLoS One 2013;8:e65724. [PMID: 23840359 DOI: 10.1371/journal.pone.0065724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 440 |
Tzeng ST, Tsai MH, Chen CL, Lee JX, Jao TM, Yu SL, Yen SJ, Yang YC. NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer. PLoS One. 2013;8:e67040. [PMID: 23825612 DOI: 10.1371/journal.pone.0067040] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 441 |
Tänzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140:133-147. [PMID: 23791941 DOI: 10.1016/j.pharmthera.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 442 |
Leko V, Park GJ, Lao U, Simon JA, Bedalov A. Enterocyte-specific inactivation of SIRT1 reduces tumor load in the APC(+/min) mouse model. PLoS One 2013;8:e66283. [PMID: 23799088 DOI: 10.1371/journal.pone.0066283] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 443 |
Ashktorab H, Hassanzadeh Namin H, Taylor T, Williams C, Brim H, Mellman T, Shokrani B, Holt CL, Laiyemo AO, Nouraie M. Role of life events in the presence of colon polyps among African Americans. BMC Gastroenterol 2013;13:101. [PMID: 23758671 DOI: 10.1186/1471-230X-13-101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 444 |
Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS, Chen DL, Bai L, Xu RH. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med 2013;11:142. [PMID: 23758705 DOI: 10.1186/1479-5876-11-142] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 445 |
Yoon K, Lee S, Han TS, Moon SY, Yun SM, Kong SH, Jho S, Choe J, Yu J, Lee HJ. Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Res. 2013;23:1109-1117. [PMID: 23737375 DOI: 10.1101/gr.145706.112] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 446 |
Arnason T, Pino MS, Yilmaz O, Kirley SD, Rueda BR, Chung DC, Zukerberg LR. Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice. Cancer Biol Ther 2013;14:672-8. [PMID: 23792637 DOI: 10.4161/cbt.25089] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 447 |
Hu Y, McIntosh GH, Le Leu RK, Nyskohus LS, Woodman RJ, Young GP. Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers. PLoS One. 2013;8:e64362. [PMID: 23717604 DOI: 10.1371/journal.pone.0064362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 448 |
Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S, Grady WM. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene 2014;33:1538-47. [PMID: 23604118 DOI: 10.1038/onc.2013.102] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 449 |
Piazzi G, Selgrad M, Garcia M, Ceccarelli C, Fini L, Bianchi P, Laghi L, D'Angelo L, Paterini P, Malfertheiner P, Chieco P, Boland CR, Bazzoli F, Ricciardiello L. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers. Br J Cancer 2013;108:1750-6. [PMID: 23579212 DOI: 10.1038/bjc.2013.142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 450 |
Zhang JX, Wang K, Mao ZF, Fan X, Jiang DL, Chen M, Cui L, Sun K, Dang SC. Application of liposomes in drug development--focus on gastroenterological targets. Int J Nanomedicine. 2013;8:1325-1334. [PMID: 23630417 DOI: 10.2147/ijn.s42153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 451 |
Datta K, Suman S, Kallakury BV, Fornace AJ Jr. Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater β-catenin activation than γ radiation in APC(Min/+) mice. PLoS One 2013;8:e59295. [PMID: 23555653 DOI: 10.1371/journal.pone.0059295] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 452 |
Simões AE, Pereira DM, Amaral JD, Nunes AF, Gomes SE, Rodrigues PM, Lo AC, D'Hooge R, Steer CJ, Thibodeau SN, Borralho PM, Rodrigues CM. Efficient recovery of proteins from multiple source samples after TRIzol(®) or TRIzol(®)LS RNA extraction and long-term storage. BMC Genomics 2013;14:181. [PMID: 23496794 DOI: 10.1186/1471-2164-14-181] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 453 |
Chen W, Xiang J, Chen DF, Ni BB, Chen H, Fan XJ, Wang PN, Song SX, Fang LK, Xiao HY, Wang L, Wang JP. Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip. Mol Biol Rep 2013;40:3457-64. [PMID: 23471507 DOI: 10.1007/s11033-012-2338-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 454 |
Campbell PT. The Role of Diabetes and Diabetes Treatments in Colorectal Cancer Mortality, Incidence, and Survival. Curr Nutr Rep 2013;2:37-47. [DOI: 10.1007/s13668-012-0034-y] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 455 |
Donada M, Bonin S, Barbazza R, Pettirosso D, Stanta G. Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. BMC Gastroenterol 2013;13:36. [PMID: 23446022 DOI: 10.1186/1471-230X-13-36] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 456 |
Hoang D, Sue GR, Xu F, Li P, Narayan D. Absence of aneuploidy and gastrointestinal tumours in a man with a chromosomal 2q13 deletion and BUB1 monoallelic deficiency. BMJ Case Rep 2013;2013:bcr2013008684. [PMID: 23440991 DOI: 10.1136/bcr-2013-008684] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 457 |
Chen L, Jiang B, Wang Z, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Cui M, Su X. Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer. Med Oncol 2013;30:498. [PMID: 23423786 DOI: 10.1007/s12032-013-0498-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 458 |
Loo LW, Tiirikainen M, Cheng I, Lum-Jones A, Seifried A, Church JM, Gryfe R, Weisenberger DJ, Lindor NM, Gallinger S. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Genes Chromosomes Cancer. 2013;52:450-466. [PMID: 23341073 DOI: 10.1002/gcc.22043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 459 |
NUCLEOTIDE EXCISION REPAIR (NER). DNA Repair and Cancer 2013. [DOI: 10.1201/b14587-6] [Reference Citation Analysis]
|
| 460 |
Maffei F, Angelini S, Cantelli Forti G, Hrelia P. Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia. Curr Colorectal Cancer Rep 2013;9:85-94. [DOI: 10.1007/s11888-012-0156-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 461 |
Zhang Y, Gu Y, Sha S, Kong X, Zhu H, Xu B, Li Y, Wu K. DBC1 is over-expressed and associated with poor prognosis in colorectal cancer. Int J Clin Oncol 2014;19:106-12. [DOI: 10.1007/s10147-012-0506-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 462 |
Geurts van Kessel A, Venkatachalam R, Kuiper RP. Colorectal Cancer. Genomic and Personalized Medicine 2013. [DOI: 10.1016/b978-0-12-382227-7.00062-8] [Reference Citation Analysis]
|
| 463 |
Hartmann D, Friess H. Adenocarcinomas. Brenner's Encyclopedia of Genetics 2013. [DOI: 10.1016/b978-0-12-374984-0.00014-0] [Reference Citation Analysis]
|
| 464 |
Oliveira MJ, Velho S. The Association Between Inflammation and Colorectal Cancer. Molecular Pathogenesis of Colorectal Cancer 2013. [DOI: 10.1007/978-1-4614-8412-7_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 465 |
Dixon DA, Blanco FF, Bruno A, Patrignani P. Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results Cancer Res 2013;191:7-37. [PMID: 22893198 DOI: 10.1007/978-3-642-30331-9_2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 466 |
Rüschoff J, Büttner R. Hereditäre Tumoren. Pathologie 2013. [DOI: 10.1007/978-3-642-02322-4_34] [Reference Citation Analysis]
|
| 467 |
Scott FI, Lynch JP. Mechanisms of Gastrointestinal Carcinogenesis. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_1] [Reference Citation Analysis]
|
| 468 |
Riegert-Johnson DL, Boardman LA, Crook JE, Thomas CS, Johnson RA, Roberts ME. Shorter peripheral blood telomeres are a potential biomarker for patients with advanced colorectal adenomas. Int J Biol Markers 2012;27:e375-80. [PMID: 22865299 DOI: 10.5301/JBM.2012.9347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 469 |
Tseng-Rogenski SS, Chung H, Wilk MB, Zhang S, Iwaizumi M, Carethers JM. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells. PLoS One. 2012;7:e50616. [PMID: 23226332 DOI: 10.1371/journal.pone.0050616] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 470 |
Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229-244. [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6] [Cited by in Crossref: 343] [Cited by in F6Publishing: 368] [Article Influence: 31.2] [Reference Citation Analysis]
|
| 471 |
Moya P, Esteban S, Fernandez-Suarez A, Maestro M, Morente M, Sánchez-Carbayo M. KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer. Tumour Biol. 2013;34:471-479. [PMID: 23132294 DOI: 10.1007/s13277-012-0572-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 472 |
Raulinaitytė D, Ugenskienė R, Jančiauskienė R, Juozaitytė E, Kairevičė L. Genai svarbūs storosios žarnos vėžio patogenezėje. Sveikatos mokslai 2012;22:77-84. [DOI: 10.5200/sm-hs.2012.101] [Reference Citation Analysis]
|
| 473 |
Salari K, Spulak ME, Cuff J, Forster AD, Giacomini CP, Huang S, Ko ME, Lin AY, van de Rijn M, Pollack JR. CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc Natl Acad Sci U S A 2012;109:E3196-205. [PMID: 23112155 DOI: 10.1073/pnas.1206004109] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 474 |
Sawada T, Yamamoto E, Suzuki H, Nojima M, Maruyama R, Shioi Y, Akasaka R, Kamimae S, Harada T, Ashida M. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization. Genes Chromosomes Cancer. 2013;52:140-149. [PMID: 23073979 DOI: 10.1002/gcc.22013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 475 |
Yamamoto E, Suzuki H, Yamano HO, Maruyama R, Nojima M, Kamimae S, Sawada T, Ashida M, Yoshikawa K, Kimura T. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Am J Pathol. 2012;181:1847-1861. [PMID: 22995252 DOI: 10.1016/j.ajpath.2012.08.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 476 |
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3:153-173. [PMID: 22943008 DOI: 10.3978/j.issn.2078-6891.2012.030] [Cited by in F6Publishing: 195] [Reference Citation Analysis]
|
| 477 |
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3:153-173. [PMID: 22943008 DOI: 10.3978j/issn.2078-6891.2012.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 478 |
Ayanian JZ, Carethers JM. Bridging behavior and biology to reduce socioeconomic disparities in colorectal cancer risk. J Natl Cancer Inst 2012;104:1343-4. [PMID: 22952312 DOI: 10.1093/jnci/djs356] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 479 |
Carethers JM. Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer. J Gastrointest Surg 2012;16:1648-50. [PMID: 22760966 DOI: 10.1007/s11605-012-1942-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 480 |
Waldner MJ, Neurath MF. Potential avenues for immunotherapy of colitis-associated neoplasia. Immunotherapy 2012;4:397-405. [PMID: 22512634 DOI: 10.2217/imt.12.15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 481 |
Bozzao C, Lastella P, Stella A. Anticipation in lynch syndrome: where we are where we go. Curr Genomics 2011;12:451-65. [PMID: 22547953 DOI: 10.2174/138920211797904070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 482 |
Subramaniam MM, Loh M, Chan JY, Liem N, Lim PL, Peng YW, Lim XY, Yeoh KG, Iacopetta B, Soong R, Salto-Tellez M. The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers. Mol Carcinog 2014;53:98-108. [PMID: 22911899 DOI: 10.1002/mc.21951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 483 |
Kim HA, Koo BK, Cho JH, Kim YY, Seong J, Chang HJ, Oh YM, Stange DE, Park JG, Hwang D. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest. 2012;122:3248-3259. [PMID: 22863622 DOI: 10.1172/jci61216] [Cited by in Crossref: 89] [Cited by in F6Publishing: 100] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 484 |
Roy S, Majumdar AP. Signaling in colon cancer stem cells. J Mol Signal. 2012;7:11. [PMID: 22866952 DOI: 10.1186/1750-2187-7-11] [Cited by in Crossref: 48] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 485 |
Hazra A, Ogino S. Epigenomic diversity of colorectal cancer. Epigenomics 2012. [DOI: 10.1017/cbo9780511777271.042] [Reference Citation Analysis]
|
| 486 |
Kang HJ, Kim EJ, Kim BG, You CH, Lee SY, Kim DI, Hong YS. Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patients. J Prev Med Public Health. 2012;45:251-258. [PMID: 22880157 DOI: 10.3961/jpmph.2012.45.4.251] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 487 |
Pancione M, Remo A, Colantuoni V. Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int. 2012;2012:509348. [PMID: 22888469 DOI: 10.1155/2012/509348] [Cited by in Crossref: 74] [Cited by in F6Publishing: 106] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 488 |
Laburthe M, Voisin T. The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs. Br J Pharmacol 2012;165:1678-87. [PMID: 21627633 DOI: 10.1111/j.1476-5381.2011.01510.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 489 |
Wang D, Zhang LM, Zhai JX, Liu DW. GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: a meta-analysis. Int J Colorectal Dis 2012;27:901-9. [PMID: 22237425 DOI: 10.1007/s00384-011-1406-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 490 |
Bauer J, Sporn JC, Cabral J, Gomez J, Jung B. Effects of activin and TGFβ on p21 in colon cancer. PLoS One 2012;7:e39381. [PMID: 22761777 DOI: 10.1371/journal.pone.0039381] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 491 |
Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J. 2011;17:405-415. [PMID: 22157284 DOI: 10.1097/ppo.0b013e318237e408] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 492 |
Legolvan MP, Taliano RJ, Resnick MB. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach. Hum Pathol. 2012;43:1157-1168. [PMID: 22658275 DOI: 10.1016/j.humpath.2012.03.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 493 |
Chan CK, Goh BH, Kamarudin MN, Kadir HA. Aqueous fraction of Nephelium ramboutan-ake rind induces mitochondrial-mediated apoptosis in HT-29 human colorectal adenocarcinoma cells. Molecules 2012;17:6633-57. [PMID: 22728359 DOI: 10.3390/molecules17066633] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 494 |
Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int. 2012;2012:597497. [PMID: 22997602 DOI: 10.1155/2012/597497] [Cited by in Crossref: 29] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 495 |
Chou J, Voong LN, Mortales CL, Towlerton AM, Pollack SM, Chen X, Yee C, Robbins PF, Warren EH. Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. J Immunother 2012;35:131-41. [PMID: 22306901 DOI: 10.1097/CJI.0b013e31824300c7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 496 |
Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM. Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr. 2012;3:3. [PMID: 22494821 DOI: 10.1186/2041-9414-3-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 497 |
Olaru AV, Cheng Y, Agarwal R, Yang J, David S, Abraham JM, Yu W, Kwon JH, Lazarev M, Brant SR, Marohn MR, Hutcheon DF, Harpaz N, Meltzer SJ, Mori Y. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm Bowel Dis 2012;18:641-8. [PMID: 21830278 DOI: 10.1002/ibd.21826] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 498 |
Hernández-losa J, Sanz J, Landolfi S, López-ríos F, Palacios J, Bautista MD, Díaz-rubio E, Tabernero J, García Foncillas J, Ramón y Cajal S. Recomendaciones para la determinación de mutaciones de K-RAS en cáncer de colon. Revista Española de Patología 2012;45:76-85. [DOI: 10.1016/j.patol.2011.11.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 499 |
Sandhu S, Wu X, Nabi Z, Rastegar M, Kung S, Mai S, Ding H. Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer 2012;11:18. [PMID: 22452792 DOI: 10.1186/1476-4598-11-18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 500 |
Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM, Peng ZH. Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta 2012;1822:918-26. [PMID: 22426038 DOI: 10.1016/j.bbadis.2012.02.021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 501 |
Ernberg I, Karimi M, Ekström TJ. Epigenetic mechanisms as targets and companions of viral assaults: Ernberg et al. Annals of the New York Academy of Sciences 2011;1230:E29-36. [DOI: 10.1111/j.1749-6632.2011.06357.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 502 |
Barone M, Lofano K, De Tullio N, Licinio R, Albano F, Di Leo A. Dietary, endocrine, and metabolic factors in the development of colorectal cancer. J Gastrointest Cancer 2012;43:13-9. [PMID: 22045273 DOI: 10.1007/s12029-011-9332-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 503 |
Weiss JM, Pfau PR. New Era for Stool Screening Tests: Fecal Immunochemical Tests, DNA, and Beyond. Curr Colorectal Cancer Rep 2012;8:1-5. [DOI: 10.1007/s11888-011-0111-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 504 |
Iwami S, Haeno H, Michor F. A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability. PLoS Comput Biol 2012;8:e1002370. [PMID: 22359489 DOI: 10.1371/journal.pcbi.1002370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 505 |
Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res. 2012;18:1506-1512. [PMID: 22302899 DOI: 10.1158/1078-0432.ccr-11-1469] [Cited by in Crossref: 172] [Cited by in F6Publishing: 188] [Article Influence: 15.6] [Reference Citation Analysis]
|
| 506 |
de Miranda NFCC, Hes FJ, van Wezel T, Morreau H. Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers. Mutagenesis 2012;27:247-53. [DOI: 10.1093/mutage/ger077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 507 |
Migheli F, Migliore L. Epigenetics of colorectal cancer. Clin Genet 2012;81:312-8. [PMID: 22263639 DOI: 10.1111/j.1399-0004.2011.01829.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 508 |
Esteban S, Moya P, Fernandez-Suarez A, Vidaurreta M, González-Peramato P, Sánchez-Carbayo M. Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer. Tumour Biol 2012;33:337-46. [PMID: 22252522 DOI: 10.1007/s13277-012-0320-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 509 |
van Lier MG, Leenen CH, Wagner A, Ramsoekh D, Dubbink HJ, van den Ouweland AM, Westenend PJ, de Graaf EJ, Wolters LM, Vrijland WW, Kuipers EJ, van Leerdam ME, Steyerberg EW, Dinjens WN; LIMO Study Group. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. J Pathol 2012;226:764-74. [PMID: 22081473 DOI: 10.1002/path.3963] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 510 |
Song BP, Jain S, Lin SY, Chen Q, Block TM, Song W, Brenner DE, Su YH. Detection of hypermethylated vimentin in urine of patients with colorectal cancer. J Mol Diagn. 2012;14:112-119. [PMID: 22251609 DOI: 10.1016/j.jmoldx.2011.12.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 511 |
Khare S, Verma M. Epigenetics of colon cancer. Methods Mol Biol 2012;863:177-85. [PMID: 22359293 DOI: 10.1007/978-1-61779-612-8_10] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 512 |
Lee SY, Miyai K, Han HS, Hwang DY, Seong MK, Chung H, Jung BH, Devaraj B, McGuire KL, Carethers JM. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia. Dig Dis Sci 2012;57:72-8. [PMID: 21773681 DOI: 10.1007/s10620-011-1825-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 513 |
Yang VW. The Cell Cycle. Physiology of the Gastrointestinal Tract 2012. [DOI: 10.1016/b978-0-12-382026-6.00015-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 514 |
Yen EF, Pokhrel B, Bianchi LK, Roy HK, Du H, Patel A, Hall CR, Witt BL. Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. Dig Dis Sci 2012;57:161-9. [PMID: 21847567 DOI: 10.1007/s10620-011-1852-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 515 |
Pinney SE, Simmons RA. Metabolic Programming, Epigenetics, and Gestational Diabetes Mellitus. Curr Diab Rep 2012;12:67-74. [DOI: 10.1007/s11892-011-0248-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 516 |
Yagi K, Takahashi H, Akagi K, Matsusaka K, Seto Y, Aburatani H, Nakajima A, Kaneda A. Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma. Am J Pathol. 2012;180:616-625. [PMID: 22115708 DOI: 10.1016/j.ajpath.2011.10.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 517 |
Luo Y, Chen D, Song S, Wang L, Wang J. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta-analysis: Methylated stool DNA detection in CRC and adenoma. International Journal of Clinical Practice 2011;65:1313-20. [DOI: 10.1111/j.1742-1241.2011.02800.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 518 |
Sillars-hardebol AH, Carvalho B, van Engeland M, Fijneman RJ, Meijer GA. The adenoma hunt in colorectal cancer screening: defining the target. J Pathol 2012;226:1-6. [DOI: 10.1002/path.3012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 519 |
Jia Y, Guo M. Epigenetic changes in colorectal cancer. Chin J Cancer. 2013;32:21-30. [PMID: 22059907 DOI: 10.5732/cjc.011.10245] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 520 |
Bakhtiarizadeh MR, Ebrahimi M, Ebrahimie E. Discovery of EST-SSRs in lung cancer: tagged ESTs with SSRs lead to differential amino acid and protein expression patterns in cancerous tissues. PLoS One 2011;6:e27118. [PMID: 22073269 DOI: 10.1371/journal.pone.0027118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 521 |
Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011;8:686-700. [PMID: 22009203 DOI: 10.1038/nrgastro.2011.173] [Cited by in Crossref: 432] [Cited by in F6Publishing: 466] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 522 |
Chung H, Chaudhry J, Lai JF, Young DJ, Carethers JM. Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2). Mutat Res 2012;729:73-80. [PMID: 22001236 DOI: 10.1016/j.mrfmmm.2011.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 523 |
Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SR. Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res. 2011;17:7283-7293. [PMID: 21948089 DOI: 10.1158/1078-0432.ccr-11-1452] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 524 |
Jain S, Singhal S, Francis F, Hajdu C, Wang JH, Suriawinata A, Wang YQ, Zhang M, Weinshel EH, Francois F, Pei ZH, Lee P, Xu RL. Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 2011; 17(35): 3994-4000 [PMID: 22046087 DOI: 10.3748/wjg.v17.i35.3994] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 525 |
Ricciardiello L, Bazzoli F, Fogliano V. Phytochemicals and colorectal cancer prevention--myth or reality? Nat Rev Gastroenterol Hepatol 2011;8:592-6. [PMID: 21894197 DOI: 10.1038/nrgastro.2011.149] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 526 |
Maffei F, Angeloni C, Malaguti M, Moraga JMZ, Pasqui F, Poli C, Colecchia A, Festi D, Hrelia P, Hrelia S. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;714:88-92. [DOI: 10.1016/j.mrfmmm.2011.06.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 527 |
Liu D, Duan W, Guo H, Xu X, Bai Y. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. Int J Colorectal Dis 2011;26:1099-105. [PMID: 21538057 DOI: 10.1007/s00384-011-1198-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 528 |
Zeng H, Yan L, Cheng WH, Uthus EO. Dietary selenomethionine increases exon-specific DNA methylation of the p53 gene in rat liver and colon mucosa. J Nutr 2011;141:1464-8. [PMID: 21653573 DOI: 10.3945/jn.111.140715] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 529 |
Carethers JM. One colon lumen but two organs. Gastroenterology 2011;141:411-2. [PMID: 21708155 DOI: 10.1053/j.gastro.2011.06.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 530 |
Lim SP, Neilsen P, Kumar R, Abell A, Callen DF. The Application of Delivery Systems for DNA Methyltransferase Inhibitors: . BioDrugs 2011;25:227-42. [DOI: 10.2165/11592770-000000000-00000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 531 |
Harrison S, Benziger H. The molecular biology of colorectal carcinoma and its implications: A review. The Surgeon 2011;9:200-10. [DOI: 10.1016/j.surge.2011.01.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 532 |
Sinicrope FA, Yang ZJ. Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer. Future Oncol 2011;7:467-74. [PMID: 21417908 DOI: 10.2217/fon.11.5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 533 |
Carethers JM. Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor. Therap Adv Gastroenterol 2008;1:33-42. [PMID: 21180512 DOI: 10.1177/1756283X08093607] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 534 |
Rizzo A, Pallone F, Monteleone G, Fantini MC. Intestinal inflammation and colorectal cancer: A double-edged sword? World J Gastroenterol 2011; 17(26): 3092-3100 [PMID: 21912451 DOI: 10.3748/wjg.v17.i26.3092] [Cited by in F6Publishing: 51] [Reference Citation Analysis]
|
| 535 |
Ly P, Eskiocak U, Kim SB, Roig AI, Hight SK, Lulla DR, Zou YS, Batten K, Wright WE, Shay JW. Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells. Neoplasia 2011;13:348-57. [PMID: 21472139 DOI: 10.1593/neo.101580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 536 |
Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI. CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer. Genes Immun 2011;12:653-62. [PMID: 21716316 DOI: 10.1038/gene.2011.43] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 537 |
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 2011;396:1017-1026. [PMID: 21706233 DOI: 10.1007/s00423-011-0812-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 538 |
Kohsaka S, Sasai K, Takahashi K, Akagi T, Tanino M, Kimura T, Nishihara H, Tanaka S. A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformation. Biochem Biophys Res Commun 2011;410:878-84. [PMID: 21703241 DOI: 10.1016/j.bbrc.2011.06.082] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 539 |
Daraei A, Salehi R, Mohamadhashem F. DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population. J Res Med Sci 2011;16:807-13. [PMID: 22091311] [Reference Citation Analysis]
|
| 540 |
Nougayrède J, Oswald É. Microbiote et cancer colorectal : des bactéries génotoxiques dans le tractus intestinal. Bulletin de l'Académie Nationale de Médecine 2011;195:1295-305. [DOI: 10.1016/s0001-4079(19)31989-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 541 |
Catenacci DV, Kozloff M, Kindler HL, Polite B. Personalized colon cancer care in 2010. Semin Oncol 2011;38:284-308. [PMID: 21421118 DOI: 10.1053/j.seminoncol.2011.01.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 542 |
Liu HG, Chen C, Yang H, Pan YF, Zhang XH. Cancer stem cell subsets and their relationships. J Transl Med 2011;9:50. [PMID: 21542915 DOI: 10.1186/1479-5876-9-50] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 543 |
M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis 2011;26:533-52. [PMID: 21311893 DOI: 10.1007/s00384-011-1137-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 544 |
Pan J, Zhong J, Gan LH, Chen SJ, Jin HC, Wang X, Wang LJ. Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer. Tumour Biol. 2011;32:729-735. [PMID: 21523445 DOI: 10.1007/s13277-011-0174-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 545 |
Zhang Z, Hu W. A single nucleotide polymorphism in XRCC4 gene is associated with reduced colorectal cancer susceptibility in female. Journal of Medical Colleges of PLA 2011;26:85-93. [DOI: 10.1016/s1000-1948(11)60030-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 546 |
Kulendran M, Stebbing JF, Marks CG, Rockall TA. Predictive and prognostic factors in colorectal cancer: a personalized approach. Cancers (Basel). 2011;3:1622-1638. [PMID: 24212777 DOI: 10.3390/cancers3021622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 547 |
Ned RM, Melillo S, Marrone M. Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test. PLoS Curr 2011;3:RRN1220. [PMID: 21487548 DOI: 10.1371/currents.RRN1220] [Cited by in Crossref: 52] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 548 |
Abdulovic AL, Hile SE, Kunkel TA, Eckert KA. The in vitro fidelity of yeast DNA polymerase δ and polymerase ε holoenzymes during dinucleotide microsatellite DNA synthesis. DNA Repair (Amst) 2011;10:497-505. [PMID: 21429821 DOI: 10.1016/j.dnarep.2011.02.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 549 |
Lund EK, Belshaw NJ, Elliott GO, Johnson IT. Recent advances in understanding the role of diet and obesity in the development of colorectal cancer. Proc Nutr Soc. 2011;70:194-204. [PMID: 21385524 DOI: 10.1017/s0029665111000073] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 550 |
Hutchins G, Southward K, Handley K, Magill L, Beaumont C, Stahlschmidt J, Richman S, Chambers P, Seymour M, Kerr D, Gray R, Quirke P. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol. 2011;29:1261-1270. [PMID: 21383284 DOI: 10.1200/jco.2010.30.1366] [Cited by in Crossref: 473] [Cited by in F6Publishing: 508] [Article Influence: 39.4] [Reference Citation Analysis]
|
| 551 |
Lee JK, Chan AT. Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status. Curr Colorectal Cancer Rep 2011;7:136-44. [PMID: 21572547 DOI: 10.1007/s11888-011-0091-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 552 |
Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-411. [PMID: 21036793 DOI: 10.1136/gut.2010.217182] [Cited by in Crossref: 403] [Cited by in F6Publishing: 436] [Article Influence: 33.6] [Reference Citation Analysis]
|
| 553 |
Zöller M, Jung T. The Colorectal Cancer Initiating Cell: Markers and Their Role in Liver Metastasis. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management. Dordrecht: Springer Netherlands; 2011. pp. 89-127. [DOI: 10.1007/978-94-007-0292-9_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 554 |
Bachet JB, Marechal R, Van Laethem JL. Treatment of pancreatic cancer: what can we really predict today? Cancers (Basel) 2011;3:675-99. [PMID: 24212636 DOI: 10.3390/cancers3010675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 555 |
Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Si J, Wang L, Jin H. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One 2011;6:e16916. [PMID: 21347233 DOI: 10.1371/journal.pone.0016916] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 556 |
Migliore L, Migheli F, Spisni R, Coppedè F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011;2011:792362. [PMID: 21490705 DOI: 10.1155/2011/792362] [Cited by in Crossref: 147] [Cited by in F6Publishing: 174] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 557 |
Vieth M, Quirke P, Lambert R, von Karsa L, Risio M. Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions. Virchows Arch 2011;458:21-30. [PMID: 21061132 DOI: 10.1007/s00428-010-0997-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 558 |
Barrett CW, Fingleton B, Williams A, Ning W, Fischer MA, Washington MK, Chaturvedi R, Wilson KT, Hiebert SW, Williams CS. MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Cancer Res. 2011;71:1302-1312. [PMID: 21303973 DOI: 10.1158/0008-5472.can-10-3317] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 559 |
Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol. 2011;18:2338-2347. [PMID: 21298349 DOI: 10.1245/s10434-011-1573-y] [Cited by in Crossref: 111] [Cited by in F6Publishing: 123] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 560 |
Worthley DL, Whitehall VL, Le Leu RK, Irahara N, Buttenshaw RL, Mallitt KA, Greco SA, Ramsnes I, Winter J, Hu Y, Ogino S, Young GP, Leggett BA. DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. Dig Dis Sci 2011;56:387-96. [PMID: 20635146 DOI: 10.1007/s10620-010-1312-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 561 |
Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, Hsu L, Porter PL. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat 2011;127:297-308. [PMID: 21264507 DOI: 10.1007/s10549-010-1297-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 562 |
Young GP, Bosch LJ. Fecal Tests: From Blood to Molecular Markers. Curr Colorectal Cancer Rep. 2011;7:62-70. [PMID: 21423316 DOI: 10.1007/s11888-010-0084-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 563 |
van Engeland M, Derks S, Smits KM, Meijer GA, Herman JG. Colorectal cancer epigenetics: complex simplicity. J Clin Oncol. 2011;29:1382-1391. [PMID: 21220596 DOI: 10.1200/jco.2010.28.2319] [Cited by in Crossref: 134] [Cited by in F6Publishing: 147] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 564 |
Bachet J, Taïeb J, Mitry E, Rougier P. Tumeurs digestives : côlon — rectum. Thérapeutique du cancer 2011. [DOI: 10.1007/978-2-8178-0021-9_23] [Reference Citation Analysis]
|
| 565 |
Rödel C, Arnold D, Liersch T. Rectal Cancer. Gastrointestinal Oncology 2011. [DOI: 10.1007/978-3-642-13306-0_13] [Reference Citation Analysis]
|
| 566 |
Furlan D, Carnevali IW, Bernasconi B, Sahnane N, Milani K, Cerutti R, Bertolini V, Chiaravalli AM, Bertoni F, Kwee I, Pastorino R, Carlo C. Hierarchical clustering analysis of pathologic and molecular data identifies prognostically and biologically distinct groups of colorectal carcinomas. Mod Pathol 2011;24:126-37. [PMID: 20852594 DOI: 10.1038/modpathol.2010.179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 567 |
Protiva P. Colorectal Cancer Pathways. Colorectal Cancer Screening 2011. [DOI: 10.1007/978-1-60761-398-5_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 568 |
Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011;60:116-29. [PMID: 20921207 DOI: 10.1136/gut.2009.206250] [Cited by in Crossref: 225] [Cited by in F6Publishing: 246] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 569 |
Pinney SE, Simmons RA. Epigenetic Changes Associated with Intrauterine Growth Retardation and Adipogenesis. Obesity Before Birth 2011. [DOI: 10.1007/978-1-4419-7034-3_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 570 |
van Roon EH, de Miranda NF, van Nieuwenhuizen MP, de Meijer EJ, van Puijenbroek M, Yan PS, Huang TH, van Wezel T, Morreau H, Boer JM. Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer. Eur J Hum Genet 2011;19:307-12. [PMID: 21150880 DOI: 10.1038/ejhg.2010.187] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 571 |
Aguirre de Cárcer D, Cuív PO, Wang T, Kang S, Worthley D, Whitehall V, Gordon I, McSweeney C, Leggett B, Morrison M. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J 2011;5:801-9. [PMID: 21124491 DOI: 10.1038/ismej.2010.177] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 572 |
Chung H, Chaudhry J, Lopez CG, Carethers JM. Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner. Cancer Biol Ther 2010;10:1147-56. [PMID: 20930505 DOI: 10.4161/cbt.10.11.13447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 573 |
Wang LS, Arnold M, Huang YW, Sardo C, Seguin C, Martin E, Huang TH, Riedl K, Schwartz S, Frankel W, Pearl D, Xu Y, Winston J 3rd, Yang GY, Stoner G. Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 2011;17:598-610. [PMID: 21123457 DOI: 10.1158/1078-0432.CCR-10-1260] [Cited by in Crossref: 126] [Cited by in F6Publishing: 128] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 574 |
Baba Y, Nosho K, Shima K, Huttenhower C, Tanaka N, Hazra A, Giovannucci EL, Fuchs CS, Ogino S. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastroenterology 2010;139:1855-64. [PMID: 20682317 DOI: 10.1053/j.gastro.2010.07.050] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 575 |
Shibao K, Fiedler MJ, Nagata J, Minagawa N, Hirata K, Nakayama Y, Iwakiri Y, Nathanson MH, Yamaguchi K. The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. Cell Calcium 2010;48:315-23. [PMID: 21075448 DOI: 10.1016/j.ceca.2010.09.005] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 576 |
Huang YW, Kuo CT, Stoner K, Huang TH, Wang LS. An overview of epigenetics and chemoprevention. FEBS Lett. 2011;585:2129-2136. [PMID: 21056563 DOI: 10.1016/j.febslet.2010.11.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 577 |
Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, de Bruijn DR, Kuiper RP, Geurts van Kessel A. The epigenetics of (hereditary) colorectal cancer. Cancer Genet Cytogenet 2010;203:1-6. [PMID: 20951312 DOI: 10.1016/j.cancergencyto.2010.08.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 578 |
Lee SY, Chung H, Devaraj B, Iwaizumi M, Han HS, Hwang DY, Seong MK, Jung BH, Carethers JM. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias. Gastroenterology 2010;139:1519-25. [PMID: 20708618 DOI: 10.1053/j.gastro.2010.08.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 579 |
Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci 2011;119:20-40. [PMID: 20947717 DOI: 10.1093/toxsci/kfq320] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 580 |
Mrkonjic M, Roslin NM, Greenwood CM, Raptis S, Pollett A, Laird PW, Pethe VV, Chiang T, Daftary D, Dicks E, Thibodeau SN, Gallinger S, Parfrey PS, Younghusband HB, Potter JD, Hudson TJ, McLaughlin JR, Green RC, Zanke BW, Newcomb PA, Paterson AD, Bapat B. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. PLoS One 2010;5:e13314. [PMID: 20967208 DOI: 10.1371/journal.pone.0013314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 581 |
Greco SA, Chia J, Inglis KJ, Cozzi SJ, Ramsnes I, Buttenshaw RL, Spring KJ, Boyle GM, Worthley DL, Leggett BA, Whitehall VL. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer 2010;10:494. [PMID: 20846368 DOI: 10.1186/1471-2407-10-494] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 582 |
Huang SC, Lee JK, Smith EJ, Doctolero RT, Tajima A, Beck SE, Weidner N, Carethers JM. Evidence for an hMSH3 defect in familial hamartomatous polyps. Cancer 2011;117:492-500. [PMID: 20845481 DOI: 10.1002/cncr.25445] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 583 |
Bellam N, Pasche B. Tgf-beta signaling alterations and colon cancer. Cancer Treat Res. 2010;155:85-103. [PMID: 20517689 DOI: 10.1007/978-1-4419-6033-7_5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 584 |
Levin TR, Rabeneck L. Colorectal Cancer: Population Screening and Surveillance. Evidence‐Based Gastroenterology and Hepatology 2010. [DOI: 10.1002/9781444314403.ch18] [Reference Citation Analysis]
|
| 585 |
Rousseau B, Chibaudel B, Bachet JB, Larsen AK, Tournigand C, Louvet C, André T, de Gramont A. Stage II and stage III colon cancer: treatment advances and future directions. Cancer J. 2010;16:202-209. [PMID: 20526097 DOI: 10.1097/ppo.0b013e3181ddc5bf] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 586 |
Carethers JM. Neoplasia. Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas 2010. [DOI: 10.1002/9781444328417.ch6] [Reference Citation Analysis]
|
| 587 |
Yan DW, Li DW, Yang YX, Xia J, Wang XL, Zhou CZ, Fan JW, Wen YG, Sun HC, Wang Q. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. Br J Cancer. 2010;103:961-969. [PMID: 20808312 DOI: 10.1038/sj.bjc.6605870] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 588 |
Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene. 2010;29:6464-6474. [PMID: 20802524 DOI: 10.1038/onc.2010.370] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 589 |
Poulogiannis G, Frayling IM, Arends MJ. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology. 2010;56:167-179. [PMID: 20102395 DOI: 10.1111/j.1365-2559.2009.03392.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 162] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 590 |
Jacobs ET, Martínez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW, LeRoy EC, Poynter JN, Thompson PA, Baron JA. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2010;31:1412-6. [PMID: 20558521 DOI: 10.1093/carcin/bgq127] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 591 |
Jang E, Chung DC. Hereditary colon cancer: lynch syndrome. Gut Liver 2010;4:151-60. [PMID: 20559516 DOI: 10.5009/gnl.2010.4.2.151] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 592 |
Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:11537-11542. [PMID: 20534522 DOI: 10.1073/pnas.1001261107] [Cited by in Crossref: 495] [Cited by in F6Publishing: 533] [Article Influence: 38.1] [Reference Citation Analysis]
|
| 593 |
Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-2114.e5. [PMID: 20420949 DOI: 10.1053/j.gastro.2010.01.058] [Cited by in Crossref: 1333] [Cited by in F6Publishing: 1393] [Article Influence: 102.5] [Reference Citation Analysis]
|
| 594 |
Pai RK, Pai RK. Molecular Testing in Colorectal Carcinoma. Surg Pathol Clin 2010;3:429-45. [PMID: 26839139 DOI: 10.1016/j.path.2010.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 595 |
Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS, Ogino S. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer 2010;9:125. [PMID: 20507599 DOI: 10.1186/1476-4598-9-125] [Cited by in Crossref: 112] [Cited by in F6Publishing: 124] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 596 |
Vanamala J, Reddivari L, Radhakrishnan S, Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010;10:238. [PMID: 20504360 DOI: 10.1186/1471-2407-10-238] [Cited by in Crossref: 164] [Cited by in F6Publishing: 174] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 597 |
Kurotani R, Kumaki N, Naizhen X, Ward JM, Linnoila RI, Kimura S. Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans. Lung Cancer 2011;71:42-8. [PMID: 20466451 DOI: 10.1016/j.lungcan.2010.04.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 598 |
Sinicrope F, Foster NR, Sargent DJ, Thibodeau SN, Smyrk TC, O'Connell MJ; North Central Cancer Treatment Group. Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients. Cancer 2010;116:1691-8. [PMID: 20186699 DOI: 10.1002/cncr.24913] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 599 |
Berg M, Agesen TH, Thiis-Evensen E, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA. Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer. 2010;9:100. [PMID: 20459617 DOI: 10.1186/1476-4598-9-100] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 600 |
Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, Shaukat A. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010;105:1189-95. [PMID: 20010923 DOI: 10.1038/ajg.2009.699] [Cited by in Crossref: 275] [Cited by in F6Publishing: 271] [Article Influence: 21.2] [Reference Citation Analysis]
|
| 601 |
Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, Del Bianco P, Nitti D, De Rossi A. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer. 2010;102:1300-1305. [PMID: 20386541 DOI: 10.1038/sj.bjc.6605644] [Cited by in Crossref: 87] [Cited by in F6Publishing: 95] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 602 |
Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010;29:181-206. [PMID: 20135198 DOI: 10.1007/s10555-010-9207-6] [Cited by in Crossref: 210] [Cited by in F6Publishing: 227] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 603 |
Bachet J, Laurent-puig P, de Gramont A, André T. Microsatellite Status and Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Curr Colorectal Cancer Rep 2010;6:148-57. [DOI: 10.1007/s11888-010-0054-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 604 |
Chung H, Lopez CG, Holmstrom J, Young DJ, Lai JF, Ream-Robinson D, Carethers JM. Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair. Hum Mol Genet 2010;19:2638-47. [PMID: 20418486 DOI: 10.1093/hmg/ddq151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 605 |
Pino MS, Kikuchi H, Zeng M, Herraiz MT, Sperduti I, Berger D, Park DY, Iafrate AJ, Zukerberg LR, Chung DC. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology 2010;138:1406-17. [PMID: 20026115 DOI: 10.1053/j.gastro.2009.12.010] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 606 |
Pinney SE, Simmons RA. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab 2010;21:223-9. [PMID: 19864158 DOI: 10.1016/j.tem.2009.10.002] [Cited by in Crossref: 129] [Cited by in F6Publishing: 144] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 607 |
Baba Y, Nosho K, Shima K, Goessling W, Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS, Ogino S. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 2010;19:822-31. [PMID: 20200425 DOI: 10.1158/1055-9965.EPI-09-1154] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 608 |
Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2010;25:313-21. [PMID: 20033188 DOI: 10.1007/s00384-009-0866-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 609 |
Studzinski GP, Wang X, Danilenko M. DNA damage response: a barrier or a path to tumor progression? Cancer Biol Ther 2010;9:253-5. [PMID: 20061811 DOI: 10.4161/cbt.9.3.10959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 610 |
Li L, Yu C, Gao H, Li Y. Argonaute proteins: potential biomarkers for human colon cancer. BMC Cancer 2010;10:38. [PMID: 20146808 DOI: 10.1186/1471-2407-10-38] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 611 |
Chung H, Lopez CG, Young DJ, Lai JF, Holmstrom J, Ream-Robinson D, Cabrera BL, Carethers JM. Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR). Oncogene 2010;29:2172-80. [PMID: 20140012 DOI: 10.1038/onc.2009.508] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 612 |
Hollande F, Pannequin J, Joubert D. The long road to colorectal cancer therapy: Searching for the right signals. Drug Resistance Updates 2010;13:44-56. [DOI: 10.1016/j.drup.2009.01.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 613 |
Gonzalo V, Lozano JJ, Muñoz J, Balaguer F, Pellisé M, Rodríguez de Miguel C, Andreu M, Jover R, Llor X, Giráldez MD, Ocaña T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, Castellví-Bel S, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS One 2010;5:e8777. [PMID: 20098741 DOI: 10.1371/journal.pone.0008777] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 614 |
Kim JC, Choi JS, Roh SA, Cho DH, Kim TW, Kim YS. Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas. Ann Surg Oncol 2010;17:1767-76. [DOI: 10.1245/s10434-009-0901-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 615 |
Carethers JM. Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer? Curr Colorectal Cancer Rep 2010;6:24-9. [PMID: 20157368 DOI: 10.1007/s11888-009-0038-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 616 |
Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, Costa A, Leo E, Pilotti S. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosomes Cancer. 2009;48:953-962. [PMID: 19672874 DOI: 10.1002/gcc.20697] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 617 |
Yang G, Fu H, Zhang J, Lu X, Yu F, Jin L, Bai L, Huang B, Shen L, Feng Y, Yao L, Lu Z. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010;138:231-40.e1-5. [PMID: 19686745 DOI: 10.1053/j.gastro.2009.08.001] [Cited by in Crossref: 87] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 618 |
Devaraj B, Lee A, Cabrera BL, Miyai K, Luo L, Ramamoorthy S, Keku T, Sandler RS, McGuire KL, Carethers JM. Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg 2010;14:1521-8. [PMID: 20844976 DOI: 10.1007/s11605-010-1340-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 619 |
Surai P, Fisinin VI. Ill Health Effects of Food Lipids: Consequences of Inadequate Food Processing, Storage and Cooking. Modern Dietary Fat Intakes in Disease Promotion 2010. [DOI: 10.1007/978-1-60327-571-2_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 620 |
Bresalier RS. Colorectal Cancer. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00123-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 621 |
Porquet N, Gout S, Huot J. The Metastatic Process: An Overview. Metastasis of Colorectal Cancer 2010. [DOI: 10.1007/978-90-481-8833-8_1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 622 |
Worthley DL, Whitehall VLJ, Buttenshaw RL, Irahara N, Greco SA, Ramsnes I, Mallitt K-, Le Leu RK, Winter J, Hu Y, Ogino S, Young GP, Leggett BA. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 2010;29:1653-62. [DOI: 10.1038/onc.2009.449] [Cited by in Crossref: 82] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 623 |
Trosko JE, Chang CC. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment. Toxicology 2010;270:18-34. [PMID: 19948204 DOI: 10.1016/j.tox.2009.11.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 624 |
Peng J, Zhang Q, Ma Y, Wang Y, Huang L, Zhang P, Chen J, Qin H. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis. Electrophoresis. 2009;30:2976-2987. [PMID: 19711377 DOI: 10.1002/elps.200900203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 625 |
Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 2009;70:1182-99. [PMID: 19879563 DOI: 10.1016/j.gie.2009.09.015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 626 |
van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. J Cell Mol Med 2010;14:181-97. [PMID: 19929944 DOI: 10.1111/j.1582-4934.2009.00977.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 627 |
Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009;9:401. [PMID: 19922656 DOI: 10.1186/1471-2407-9-401] [Cited by in Crossref: 252] [Cited by in F6Publishing: 269] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 628 |
Paun BC, Cheng Y, Leggett BA, Young J, Meltzer SJ, Mori Y. Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors. PLoS One 2009;4:e7715. [PMID: 19888451 DOI: 10.1371/journal.pone.0007715] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 629 |
Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V. UGT genomic diversity: beyond gene duplication. Drug Metabolism Reviews 2010;42:24-44. [DOI: 10.3109/03602530903210682] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 630 |
Zambirinis CP, Theodoropoulos G, Gazouli M. Undefined familial colorectal cancer. World J Gastrointest Oncol 2009; 1(1): 12-20 [PMID: 21160768 DOI: 10.4251/wjgo.v1.i1.12] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 631 |
Demidov ON, Cha H, Bulavin DV, Fornace AJ. Wip1, an oncogene targeting tumor suppressors expressed in intestinal stem cells. Curr colorectal cancer rep 2009;5:197-202. [DOI: 10.1007/s11888-009-0027-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 632 |
McGarrity TJ, Amos C. Less common colorectal cancer predisposition syndromes. Surg Oncol Clin N Am 2009;18:647-61. [PMID: 19793572 DOI: 10.1016/j.soc.2009.07.005] [Reference Citation Analysis]
|
| 633 |
Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Meyerhardt JA, Fuchs CS. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol. 2009;27:4591-4598. [PMID: 19704056 DOI: 10.1200/jco.2009.22.8858] [Cited by in Crossref: 80] [Cited by in F6Publishing: 95] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 634 |
Kerschgens J, Egener-kuhn T, Mermod N. Protein-binding microarrays: probing disease markers at the interface of proteomics and genomics. Trends in Molecular Medicine 2009;15:352-8. [DOI: 10.1016/j.molmed.2009.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 635 |
Lamoril J, Ameziane N, Deybach J, Bouizegarène P, Bogard M. KRAS et cancer colorectal : un pas de géant vers la médecine personnalisée. Immuno-analyse & Biologie Spécialisée 2009;24:196-209. [DOI: 10.1016/j.immbio.2009.05.001] [Reference Citation Analysis]
|
| 636 |
Sinicrope FA, Sargent DJ. Clinical implications of microsatellite instability in sporadic colon cancers. Curr Opin Oncol 2009;21:369-73. [PMID: 19444104 DOI: 10.1097/CCO.0b013e32832c94bd] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 637 |
Baba Y, Nosho K, Shima K, Irahara N, Kure S, Toyoda S, Kirkner GJ, Goel A, Fuchs CS, Ogino S. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 2009;11:418-25. [PMID: 19412426 DOI: 10.1593/neo.09154] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 638 |
Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009;9:489-99. [PMID: 19536109 DOI: 10.1038/nrc2645] [Cited by in Crossref: 496] [Cited by in F6Publishing: 515] [Article Influence: 35.4] [Reference Citation Analysis]
|
| 639 |
Carethers JM. Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis. Gastroenterology 2009;137:33-6. [PMID: 19482104 DOI: 10.1053/j.gastro.2009.05.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 640 |
Boland CR, Shin SK, Goel A. Promoter methylation in the genesis of gastrointestinal cancer. Yonsei Med J 2009;50:309-21. [PMID: 19568590 DOI: 10.3349/ymj.2009.50.3.309] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 641 |
. Current Opinion in Oncology. Current world literature. Curr Opin Oncol 2009;21:386-92. [PMID: 19509503 DOI: 10.1097/CCO.0b013e32832e] [Reference Citation Analysis]
|
| 642 |
Hei TK, Ballas LK, Brenner DJ, Geard CR. Advances in radiobiological studies using a microbeam. J Radiat Res 2009;50 Suppl A:A7-A12. [PMID: 19346688 DOI: 10.1269/jrr.08135s] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 643 |
Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009;7:682-688.e1-5. [PMID: 19245853 DOI: 10.1016/j.cgh.2009.02.016] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 644 |
deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55:1337-1346. [PMID: 19406918 DOI: 10.1373/clinchem.2008.115808] [Cited by in Crossref: 361] [Cited by in F6Publishing: 391] [Article Influence: 25.8] [Reference Citation Analysis]
|
| 645 |
Strimpakos AS, Syrigos KN, Saif MW. Pharmacogenetics and biomarkers in colorectal cancer. Pharmacogenomics J 2009;9:147-60. [DOI: 10.1038/tpj.2009.8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 646 |
Selves J, Olschwang S. [Early-onset colorectal carcinoma study]. Med Sci (Paris) 2009;25 Spec No 1:25-8. [PMID: 19361407 DOI: 10.1051/medsci/2009251s25] [Reference Citation Analysis]
|
| 647 |
Girnun G. PPARG: a new independent marker for colorectal cancer survival. Gastroenterology 2009;136:1157-60. [PMID: 19236969 DOI: 10.1053/j.gastro.2009.02.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 648 |
Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, Chen L, Toyoda S, Kirkner GJ, Wang YL, Giovannucci EL, Fuchs CS. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009;136:1242-50. [PMID: 19186181 DOI: 10.1053/j.gastro.2008.12.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 649 |
Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, Chen L, Toyoda S, Kirkner GJ, Wang YL, Giovannucci EL, Fuchs CS. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009;136:1242-50. [PMID: 19186181 DOI: 10.1053/j.gastro.2008.12.048] [Cited by in Crossref: 110] [Cited by in F6Publishing: 124] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 650 |
Zhang X, Ge YL, Tian RH. The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo. Cell Mol Biol Lett 2009;14:305-18. [PMID: 19183865 DOI: 10.2478/s11658-009-0001-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 651 |
Chung H, Young DJ, Lopez CG, Le TA, Lee JK, Ream-Robinson D, Huang SC, Carethers JM. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair. PLoS One 2008;3:e3463. [PMID: 18941508 DOI: 10.1371/journal.pone.0003463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
